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Abstract
The microorganisms that inhabit the human gastrointestinal tract comprise a
complex ecosystem with functions that significantly contribute to our systemic
metabolism and have an impact on health and disease. In line with its impor-
tance, the human gastrointestinal microbiota has been extensively studied.
Despite the fact that a significant part of the intestinal microorganisms has not
yet been cultured, presently over 1000 different microbial species that can
reside in the human gastrointestinal tract have been identified. This review
provides a systematic overview and detailed references of the total of 1057
intestinal species of Eukarya (92), Archaea (8) and Bacteria (957), based on the
phylogenetic framework of their small subunit ribosomal RNA gene sequences.
Moreover, it unifies knowledge about the prevalence, abundance, stability,
physiology, genetics and the association with human health of these gastroin-
testinal microorganisms, which is currently scattered over a vast amount of lit-
erature published in the last 150 years. This detailed physiological and genetic
information is expected to be instrumental in advancing our knowledge of the
gastrointestinal microbiota. Moreover, it opens avenues for future comparative
and functional metagenomic and other high-throughput approaches that need
a systematic and physiological basis to have an impact.
Introduction – a historical perspective
Human beings, similar to other higher organisms, live in
symbiosis with their coevolved microbiota (B€ackhed
et al., 2005). The majority of the human microorganisms
reside in the gastrointestinal tract, where, besides contrib-
uting to the digestion, they perform various other func-
tions that are essential for the human host. These
functions include the production of vitamins, education
of the immune system, communication with the intestinal
cells, and modulation of the host’s behavior (B€ackhed
et al., 2005; Cryan & Dinan, 2012; Rajilic-Stojanovic,
2013). The first report of living creatures in the human
gastrointestinal tract dates from 1681 when Antonie van
Leeuwenhoek reported a variety of ‘little animals’ in his
stool samples and identified what is now thought to be a
Giardia spp. when suffering from diarrhea (Dobell, 1932).
Almost two centuries passed before the first detailed
descriptions of pure cultures of gastrointestinal microor-
ganisms were reported, of which the earliest is most likely
the description of the eukaryal intestinal parasite Pentatri-
chomonas hominis (at the time named Trichomonas
hominis), by Casimir Davaine in 1854 (Hemmeter, 1902).
Since P. hominis, similar to other intestinal Eukarya, has
a very low prevalence, this discovery did not trigger fur-
ther analysis of the gastrointestinal microbiota. However,
intensive studies of the gastrointestinal microbiota fol-
lowed the first cultivation of the intestinal bacterium,
now known as Escherichia coli. From a historical perspec-
tive, this and several other events, here termed turning
points, can be recognized as having impacted the discov-
ery of the gastrointestinal microbiota constituents. These
turning points are evident when the number of described
gastrointestinal tract species is considered in view of time
(Fig. 1).
The first turning point (Fig. 1) marks the first descrip-
tion of a gastrointestinal bacterium, which is the isolation
of Bacterium coli commune (later renamed to E. coli), by
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the German pediatrician Teodor Escherich in 1885 (Shul-
man et al., 2007). The studies that followed shortly there-
after led to the description of representatives of a number
of the major gastrointestinal bacterial groups, including
the genera Bacteroides, Bifidobacterium, and Bacillus as
well as proteolytic cocci (Fl€ugge, 1886; Veillon & Zuber,
1898; Moro, 1900; Tissier, 1900; Passini, 1905; Tissier,
1908; Distaso, 1911). During this period that lasted till
the late sixties of the 20th century, Bifidobacterium and
Bacteroides spp. were considered to be the dominant
groups in the human gastrointestinal tract. Aerobes,
referred as coliforms, streptococci and lactobacilli, were
found as minor groups, while clostridia, staphylococci
and aerobic spore-formers were reported as rare and not
always detectable (Haenel, 1970). However, the vast
majority of the gastrointestinal microorganisms are now
known to be strict anaerobes, and this was for the first
time shown in 1931 (Sanborn, 1931). Therefore, the early
cultivation studies provided only a partial view of the gas-
trointestinal microbiota and it enabled isolation of only a
minority (10–25%) of the gastrointestinal microorganisms
(Finegold, 1969).
The improvements of anaerobic cultivation techniques
by Hungate (1969) marked the second turning point in
the gastrointestinal microbiota research, approximately
50 years ago (Fig. 1). In this second period of the gastro-
intestinal microbiota research that lasted from the early
seventies till the molecular revolution in the beginning of
this century (Fig. 1), it was recognized that the microbi-
ota in the gastrointestinal tract is dominated by bacterial
species that belong to the following genera: Bacteroides,
Clostridium, Eubacterium, Veillonella, Ruminococcus, Bifi-
dobacterium, Fusobacterium, Lactobacillus, Peptostreptococ-
cus, and Peptococcus (Moore & Holdeman, 1974a). Using
strict anaerobic techniques, it was reportedly possible to
cultivate up to 88% of the total microscopic counts in
fecal samples (Moore & Holdeman, 1974a). However, due
to the enormous complexity of the gastrointestinal micro-
biota, many of the hundreds of isolates were not charac-
terized beyond the genus level (Finegold et al., 1974;
Moore & Holdeman, 1974a; Benno et al., 1986). More-
over, as processing of even a single sample yielded an
enormous amount of different isolates, it was physically
impossible to compare these all and make a full descrip-
tion based on the morphological, biochemical and physi-
ological characteristics that could be determined at that
time (Moore & Holdeman, 1974b). Hence, due to these
technical limitations, the gastrointestinal microbiota
remained only partially characterized.
Finally, the third turning point in the gastrointestinal
microbiota research can be ascribed to the incorporation
of molecular techniques about a dozen years ago (Fig. 1).
These include global and culture-independent studies
based on the sequence analysis of the small subunit ribo-
somal RNA (SSU rRNA) that had provided the molecular
basis for microbial taxonomy that is currently used (Wo-
ese et al., 1990). However, the complexity of the gastroin-
testinal tract microbial ecosystem hampers the rapid
application of SSU rRNA-based methods as well as
(meta)genomics (Zoetendal et al., 2008). Hence, the first
gastrointestinal tract study using SSU rRNA sequences
dealt with a single adult sample (Wilson & Blitchington,
1996). Subsequent SSU rRNA-based studies in multiple
adults demonstrated the individuality, temporal stability
and site specificity of the intestinal microbiota with a
diversity that was only partially grasped in cultivation-
based studies (Zoetendal et al., 1998; Suau et al., 1999;
Zoetendal et al., 2001). These novel findings sparked a
revival of the scientific interest in the gastrointestinal mic-
robiota that was initially compared to a Renaissance
(Tannock, 1999). However, the years that followed
showed this to be more of a revolution that incorporated
metagenome and whole-genome characterizations (Nelson
et al., 2010; Qin et al., 2010; Brown et al., 2013).
When integrated with cultivation-based studies, the
analysis of the SSU rRNA gene sequences as phylogenetic
markers enabled rapid identification of the new gastroin-
testinal isolates, and illustrated the need for the reclassifi-
cation of many species. In addition, the SSU rRNA gene
sequences enabled the detection of not yet cultured
microorganisms and their phylogenetic positioning.
Finally, the research field expanded to another dimension
with the application of high-throughput approaches,
including next-generation sequencing of the SSU rRNA
gene sequences or the entire genomic material (Zoetendal









































Fig. 1. Graphical representation of the cumulative number of
cultured species from Bacteria, Archaea and Eukarya from the human
gastrointestinal tract as a function of time. The arrows indicate the
turning points of the gastrointestinal microbiota research: (1) Isolation
of the first gastrointestinal bacterial species, (2) Introduction of strictly
anaerobic techniques, and (3) Introduction of molecular techniques in
the field of the gastrointestinal microbiota research.
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baseline of over 3 million, mainly bacterial, genes present
in the human gastrointestinal tract (Qin et al., 2010;
Brown et al., 2013) and demonstrated that the majority
of the gastrointestinal microorganisms contain genomes
that have not yet been characterized (Qin et al., 2010; Le
Chatelier et al., 2013).
The present-day view of the gastrointestinal microbiota
composition is quite different than prior to the molecular
revolution. Most importantly, it is evident that still many
of the gastrointestinal microorganisms have not yet been
cultured and this in particular concerns phylogenetically
distinct bacterial groups belonging to the Firmicutes phy-
lum (Rajilic-Stojanovic et al., 2007). Furthermore, several
of the bacterial groups that based on cultivation studies
had been recognized as dominant gastrointestinal genera,
have been reclassified and renamed. Most notably this
concerns the Bacteroides spp. that have been reclassified
into the genera Alistipes, Prevotella, Paraprevotella, Para-
bacteroides, and Odoribacter. Moreover, it is evident that
different members of the Bacteroidetes phylum and not the
Bacteroides genus sensu stricto are dominant in the human
gastrointestinal tract. Furthermore, the abundance of the
Peptostreptococcus spp. demonstrated in cultivation-based
studies, could primarily be attributed to Peptostreptococco-
cus productus (Holdeman et al., 1976). However, SSU
rRNA gene analysis has shown that this species does not
belong to the genus Peptostreptococcocus, and the species
was reclassified first as Ruminococcus productus (Ezaki
et al., 1994) and finally as Blautia producta (Liu et al.,
2008). Today, it is clear that Blautia spp., in contrast to Pe-
ptostreptococcus spp., form one of the most abundant
groups in the human gastrointestinal tract. Many other so-
called dominant genera are still in need for major reclassi-
fication, and the best example of this is the Clostridium
genus, for which a detailed phylogenetic analysis led to a
proposed grouping into 19 clusters (Collins et al., 1994).
Bacteria belonging to the Clostridium spp. are highly abun-
dant in the adult gastrointestinal tract, and in particular,
the members of the species that cluster within the Clostrid-
ium cluster IV (C. leptum group, which major constituent
is the Ruminococcacea family) and the Clostridium cluster
XIVa (C. coccoides group, which resembles the Lachnospir-
aceae family). Furthermore, the Ruminococcus genus is
polyphyletic or paraphyletic and its members cluster
within two families — the Ruminococcaceae and Lachno-
spiraceae. A recent metagenomic study reported that the
abundance of Ruminococcus spp. is a driver of one of the
proposed enterotype status of the microbiota (Arumugam
et al., 2011). However, as the present metagenomic analy-
ses do not provide accurate phylogenetic information, it is
unclear which of the two distinct groups of Ruminococcus
spp., is the actual driver of this enterotype status. This
example illustrates the need for a systematic and detailed
presentation of the microbiota analysis in a phylogenetic
framework.
The extensive period of the studying of the gastrointes-
tinal microbiota, its complexity and its variation between
individuals have generated a massive amount of informa-
tion, which is scattered in the literature. To unify the
knowledge of the gastrointestinal microbiota that has
accumulated since its discovery, we have performed a
search of the publications covering more than a century
(Fig. 1). We found references that link the human gastro-
intestinal microbiota with a total of 1057 intestinal spe-
cies belonging to the Eukarya (92), Archaea (8) and
Bacteria (957; Fig. 2, Supporting information, Tables S1–
S3). These species were analyzed in ARB software-based
database of the SSU rRNA sequences (Pruesse et al.,
2007). The phylogenetic trees presented here were
extracted from the reference phylogenetic tree of the SILVA
database (Yarza et al., 2008). From this phylogenetic and
literature analysis, it is clear that bacteria that cluster
within the phyla Actinobacteria, Bacteroidetes, Firmicutes
and Proteobacteria, are the most diverse and abundant
microorganisms in the adult gastrointestinal tract (Fig. 2).
The gastrointestinal microbiota also contains members of
the less diverse, although in some cases still abundant,
bacterial phyla, including the Verrucomicrobia, Lentisphae-
rae, Synergistetes, Planctomycetes, Tenericutes and the Dei-
nococcus-Thermus group. In addition to these established
phylogenetic groups, the SSU rRNA gene sequences of
not yet cultured bacteria that cluster within the TM7 can-
didate phylum, Melainabacteria and Gemmatimonacetes,
can be detected in the human gastrointestinal tract
(Fig. 2). Several archaeal species that cluster within two
phyla have been detected in the human gastrointestinal
tract. The Euryarchaeota include the methanogens that
are relatively abundant. Among the Eukarya there are
organisms that are highly adapted to the human gastroin-
testinal tract, such as some Candida spp., while many
other eukaryote species can be present at a low abun-
dance and may be passengers. Altogether, our present
analysis confirms that the human gastrointestinal micro-
biota is composed of representatives of all three domains
of life — Bacteria, Archaea, and Eukarya.
The gastrointestinal microbiota research is very
dynamic, and in the last decade, 239 novel gastrointesti-
nal tract species have been detected or described, con-
firming the earlier notion that the majority of the
gastrointestinal microorganisms are cultivable but not yet
cultured. While traditional cultivation media and strate-
gies are efficient in obtaining novel species within the
Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria
phyla, for the detection of the gastrointestinal representa-
tives of the phyla Verrucomicrobia and Lentisphaerae, the
development of specific media and culturing approaches
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was needed (Zoetendal et al., 2003; Derrien et al., 2004).
This suggests that for the cultivation of the gastrointesti-
nal microorganisms belonging to phyla that lack any cul-
tured representatives from the human intestine (e.g.,
TM7 candidate phylum or the Oscillospira genus), alter-
native and creative cultivation approaches should be
developed and applied. Some new and promising devel-
opments include the use of high-throughput solid phase
growth (Ingham et al., 2007), advanced culturing
approaches using gnotobiotic mice (Goodman et al.,
2011), or gel microdroplet culturing (Fitzsimons et al.,
2013). The use of high-throughput culturing systems that
employ a large set of growth media coupled to genomic
characterization has proven to be very fruitful (Lagier
et al., 2012a; Dubourg et al., 2013; Hamad et al., 2013;
Pfleiderer et al., 2013). This recent attention for culturing
the gastrointestinal microorganisms reflects the perceived
need for detailed physiological, ecological and genetic
studies. While a variety of functional metagenomics
approaches have been described and applied, it is the
integration with culturing approaches that is needed to
further advance the understanding of the function of the
intestinal ecosystem in health and disease. The power of
this combination has recently been illustrated with the
example of the abundant mucus-utilizing bacterium, Akk-
ermansia muciniphila as a paradigm (Belzer & de Vos,
2012). Currently, the complete genome of at least one
strain of 225 gastrointestinal species has been fully
sequenced, assembled, and published, while many other
genomic sequencing projects are ongoing (Fig. 2,
Tables S1–S3). The physiological and genetic characteris-
tics of these currently recognized gastrointestinal species
and their association with particular functions of the eco-
system or diseases are systematized in this review that
aims to provide the basis for future comparative and
functional metagenomic and other high-throughput
approaches applied on the gastrointestinal microbiota.
Actinobacteria
Actinobacteria are common and abundant in the human
gastrointestinal tract. They are also known as gram-posi-
tive bacteria with a high G + C content in their DNA. As
they are particularly difficult to lyse and their SSU RNA
needs specific PCR primers to be amplified (Satokari
et al., 2001), this group of bacteria is often underrepre-
sented in molecular surveys of the gastrointestinal micro-
biota (notably in one of the first global studies of the
infants’ microbiota; Palmer et al., 2007). Members of the
orders Bifidobacteriales (in particular Bifidobacterium spp.)
and Coriobacteriales (mainly Collinsella spp.) are highly



















































Fig. 2. Phylogenetic tree of the human gastrointestinal microbiota. The numbers in parentheses indicate the number of cultured species given
per phylum. The pie charts illustrate distribution between the number of species with full genome sequence genome (full sectors), the number of
species with partial genome sequence (semi-full sectors) and number of species without any genome sequence (empty sectors) given for
Archaea, Eukarya and per phylum for Bacteria. The color code of pies corresponds to the color code of the phylogenetic tree.
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order Actinobacteriales are human-associated bacteria that
are subabundant and only scarcely detected in the gastro-
intestinal tract.
Actinobacteria-Bifidobacteriales
Bifidobacterium spp. form a dominant fraction of the
human gastrointestinal microbiota, particularly in infants
(Benno et al., 1984). Bifidobacteria are present in the
abundance ranging between 108 and 1010 cells g1 of
intestinal content (Finegold et al., 1974; Moore & Hold-
eman, 1974a; Tannock, 1995). The majority of Bifidobac-
terium spp. have been recovered exclusively from human
or animal gastrointestinal samples, and for two species
(B. minimum and B. subtile) that were isolated from sew-
age (Scardovi & Trovatelli, 1974), an intestinal origin can
be suspected, showing the high adaption of this genus to
the gastrointestinal tract. Phylogenetically, Bifidobacterium
spp. form a homogenous group, with 20 cultured species
linked to the human gastrointestinal tract (Fig. 3). The
first Bifidobacterium spp. was recovered from infant feces
in 1900 by Henri Tissier, as a part of his PhD thesis work
(Tissier, 1900). It was named Bacillus bifidus-communis.
Already in 1924, this bacterium was renamed to Bifido-
bacterium bifidum, but Bifidobacterium was not recognized
as an independent genus until 1974 (Biavati et al., 2000).
The members of the Bifidobacterium genus are nonmotile,
anaerobic or microaerophilic bacteria that produce ace-
tate and lactate as major fermentation products from sug-














































Fig. 3. Phylogenetic tree of the human gastrointestinal species that belong to the orders of the Bifidobacteriales and Coriobacteriales. GenBank
Accession Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated.
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performed through a phosphoketolase pathway, also
known as the Bifido shunt. Bifidobacterium spp. degrade
monosaccharides, galacto-, manno-, and fructo-oligosac-
charides, while some strains are able to ferment complex
carbohydrates such as starch, arabinogalactan, arabic
gum, and gastric mucin (Crociani et al., 1994). As
mother milk’s contains nondigestible oligosaccharides that
can be degraded by Bifidobacterium spp. (Marcobal et al.,
2011), this bacterial group is strongly stimulated in
breast-fed infants resulting in the dominance of Bifidobac-
terium spp. in the gastrointestinal microbiota before
weaning. The Bifidobacterium spp. are assumed to have a
beneficial effect on health (Mitsuoka, 1990) and several
members of the Bifidobacterium genus are commercially
applied as probiotics. The most relevant observation is
that these bacteria have decreased abundance in relation
to a number of diseases including vitamin K deficiency
(Benno et al., 1985), atopic diseases (Kalliomaki et al.,
2001), irritable bowel syndrome (Kerckhoffs et al., 2009;
Rajilic-Stojanovic et al., 2011), and autism (Wang et al.,
2011a). Moreover, Bifidobacterium spp. represent a very
stable component of the gastrointestinal microbiota of
each person, the composition of which hardly changes
throughout years (Rajilic-Stojanovic et al., 2013b).
Remarkably, a recent study of the microbiota of the Haz-
da tribe from Tanzania suggested that these adult hunter-
gatherers do not carry any Bifidobacterium spp., which
was explained by absence of dietary components such as
meat and dairy that could support growth of these bacte-
ria (Schnorr et al., 2014).
Actinobacteria-Coriobacteriales
Coriobacteriales species constitute a frequently detected
group of the gastrointestinal microbiota composed of rep-
resentatives of 12 different genera (Fig. 3). Collinsella is
the most dominant among other members of the order,
and a representative of these rod-shaped, nonmotile obli-
gate anaerobes was for the first time detected in human
feces in 1935 (Eggerth, 1935). Both cultivation- and
molecular-based studies show that Collinsella aerofaciens
is a prevalent and an abundant gastrointestinal microor-
ganism (Moore & Holdeman, 1974a; Benno et al., 1986;
Kageyama et al., 2000). Four different types of Collinsella
aerofaciens were initially recognized and later reclassified
into distinct species (Kageyama & Benno, 2000). Collinsel-
la spp. can ferment a wide range of different carbohy-
drates including complex sugars, such as starch but also
glycogen to produce hydrogen gas, ethanol, formate, and
lactate (Eggerth, 1935; Kageyama et al., 1999a). Experi-
ments with an in vitro model of the human colon showed
that Collinsella spp. along with Bifidobacterium spp. are
the major lactose utilizers in the human gastrointestinal
microbiota (Kovatcheva-Datchary, 2010). Moreover,
Collinsella spp. are capable of deconjugation of bile acids
and their abundance shows significant positive correlation
with plasma cholesterol levels (Lahti et al., 2013).
Eggerthella are assacharolytic bacteria that produce
acids only from glucose, but not from other sugars. The
first representative of this bacterial group was isolated in
1935 by Arnold Eggerth (Eggerth, 1935). These bacteria
produce formate and lactate. Until now, only Eggerthella
lenta and the still not fully characterized Eggerthella sp.
YY7918 are associated with the human gastrointestinal
tract. Eggerthella lenta has been implied in producing
anti-tumor substances that stimulate natural killer cells
(Hatta, 1995), while Eggerthella sp. YY7918 has been
reported to produce s-equol (Yokoyama & Suzuki, 2008),
which has anticarcinogenic properties (Yuan et al., 2007).
Slackia spp. are asaccharolytic bacteria with the com-
mon feature of converting dietary isoflavones. These isof-
lavones have been proposed to prevent hormone-
dependent diseases, while their conversion by gastrointes-
tinal bacteria impacts their biological effectiveness.
Among the bacterial products, s-equol appears to be the
most relevant to human physiology (Yuan et al., 2007).
At least two Slackia spp. are capable of equol production
from isoflavones (Matthies et al., 2009; Jin et al., 2010),
while Adlercreutzia equolifaciens that also belongs to the
Coriobacteriales order, is another gastrointestinal species
capable to produce equol (Maruo et al., 2008). The ability
to produce s-equol is more abundant among microbiota
of Asian than the Caucasian subjects (Song et al., 2006)
and can be explained by the adaptation of the microbiota
to the higher availability of isoflavones — particularly
those derived from soy beans.
Atopobium species are anaerobic bacteria that cluster
within the Actionobacteria phylum, and, in contrast to the
rest of the phylum, contain DNA with a low G + C con-
tent. The main product of their metabolism is lactate,
which is in line with the previous classification of these
bacteria within the Lactobacillus and Streptococcus genera
(Collins & Wallbanks, 1992). Based on the literature data,
it can be concluded that Atopobium spp. are among the
earliest colonizers of the human intestinal tract as they
are reported to be present in gastrointestinal contents of
6-week-old infants (Fallani et al., 2011). However, the
data on Atopobium quantification are based on the appli-
cation of a FISH probe for the Atopobium cluster, which
in addition to Atopobium, hybridizes to species that
belong to the Coriobacterium, Eggerthella and Collinsella
genera (Harmsen et al., 2000). Therefore, it is not clear if
the Atopobium or the other targeted genera are colonizing
the gastrointestinal tract of infants. Bacteria belonging to
the Atopobium cluster are significantly associated with the
major products of protein fermentation, suggesting that
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these bacteria are responsible for protein degradation in
the gastrointestinal tract (Shen et al., 2010; Thompson-
Chagoyan et al., 2011).
Actinobacteria-Actinomycetales
The Actinobacteria of the human gastrointestinal tract
include diverse members of the order Actinomycetales
(Figs 4 and 5 — for clarity the phylogenetic tree of this
numerous order was split into two parts). These bacteria
are rarely detected in human gastrointestinal samples, but
this is most likely due to their low abundance in the gas-
trointestinal tract that is in the range from 102 to
103 cells g1 of feces (Hoyles et al., 2012). Their low
abundance can explain the fact that many representatives
of this group were detected only in studies that specifi-
cally targeted this group of bacteria (Hoyles et al., 2013),
or in studies that targeted low abundant bacteria within
the gastrointestinal microbiota (Lagier et al., 2012a; Du-
bourg et al., 2013). Various different Actinomycetales spe-
cies, of which many are still uncultured, were identified
in a molecular study of these specific subcommunity
within the gastrointestinal microbiota of healthy humans
of different ages, showing a high prevalence of these bac-
teria (Hoyles et al., 2013). The most diverse and the fre-
quently detected Actinomycetales of the human
gastrointestinal tract include Propionibacterium spp. and
Corynebacterium spp. (Fig. 4). These bacteria typically
colonize the human skin and are found in high abun-

























































Fig. 4. Phylogenetic tree of a fraction of the human gastrointestinal species that belong to the order of the Actinomycetales. GenBank Accession
Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated. For the other human gastrointestinal
species that cluster within the Actinomycetales see Fig. 5.
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Fig. 5. Phylogenetic tree of a fraction of the human gastrointestinal species that belong to the order of the Actinomycetales. GenBank Accession
Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated. For the other human gastrointestinal
species that cluster within the Actinomycetales see Fig. 4.
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(Dominguez-Bello et al., 2010). In adults, Corynebacte-
rium spp. are more frequently detected in the samples of
the upper gastrointestinal tract (Justesen et al., 1984).
Cultivation studies have indicated that Propionibacterium
spp. are the major proteolytic bacteria in the human
intestine (Macfarlane et al., 1986). Propionibacterium spp.
are applied as probiotics as they are major vitamin B12
producers and produce propionate from lactate. In vitro
experiments showed that the metabolic products of two
gastrointestinal Propionibacterium spp. can induce apop-
tosis of colorectal carcinoma cells (Jan et al., 2002).
Bacteria belonging to the Rhodococcus genus are rarely
detected in the human gastrointestinal microbiota but
have been found in an extreme abundance (up to 68%)
in mucosal biopsies of ulcerative colitis patients (Lepage
et al., 2011). Mycobacterium spp., notably Mycobacterium
avium, have also been implied in ulcerative colitis and
the expression of intestinal cells in inflammatory bowel
disease patients appears to have similarities to Mycobacte-
rium infection (Sibartie et al., 2010).
The gastrointestinal Actinomycetales also include Rothia
spp. that are frequently detected in the upper gastrointesti-
nal tract (Ou et al., 2009), but rarely in fecal samples. These
species contribute to the degradation of gluten (Zamakh-
chari et al., 2011) and their abundance and activity might
be relevant for celiac disease and other conditions related
to gluten digestion. Another species of this order— Actino-
myces graevenitzii — which is detected in an increased
abundance in the small intestine of celiac disease patients,
might be a relevant risk factor for the development of this
disease (Ou et al., 2009). Various other Actinomyces spp.
can be detected in low abundance in the fecal samples of
healthy humans (Hoyles et al., 2012; Hoyles et al., 2013),
and while the role of these bacteria in the gastrointestinal
tract is still to be determined, it is noteworthy that an Acti-
nomyces spp. was detected as colonizer of the infant gastro-
intestinal tract using sensitive molecular methods already
in the first days of life (Favier et al., 2002).
Micrococcus spp. are relatively prevalent (present in
20% of the analyzed subjects) in the samples of the upper
gastrointestinal tract in patients predisposed to the devel-
opment of the small intestinal bacterial overgrowth syn-
drome (Bouhnik et al., 1999). Although representatives of
this genus can be detected in the fecal samples (Finegold
et al., 1974), these bacteria typically inhabit human skin.
Similar applies to six Kocuria spp., which are human skin
and oropharynx mucosa commensals (Savini et al., 2010),
although two recent studies have reported presence of
Kocuria spp. in gastrointestinal samples (Lagier et al.,
2012a; Fitzsimons et al., 2013).
The other members of the Actinomycetales order
include the representative species of the following genera:
Brevibacterium, Cellulomonas, and Microbacterium. These
genera are typically associated with other ecosystems,
namely the skin (Brevibacterium), and soil (Cellulomonas
and Microbacterium). Nevertheless, most of these bacteria
are already recognized as relevant for human health, as
many of these species can cause infections of different tis-
sues, particularly in immuno-suppressed patients (Funke
et al., 1997). It has been suggested that gastrointestinal
tract represents the natural niche of these bacteria (Funke
et al., 1997).
Bacteroidetes
The Gram-negative bacteria that belong to the phylum
Bacteroidetes are common, abundant and diverse within
the human gastrointestinal tract. The first Bacteroides spe-
cies — Bacteroides fragilis — was isolated in 1898 as a
human pathogen linked to appendicitis among other clin-
ical cases (Veillon & Zuber, 1898). Although some Bacte-
roides spp. are still considered to be opportunistic
pathogens, several decades of research have testified that
many Bacteroidetes species are highly adjusted to the gas-
trointestinal tract, where they live in high abundance (up
to 1011 cells g1 of intestinal material; Eggerth & Gagnon,
1933; Moore & Holdeman, 1974a; Benno et al., 1986).
Hence, they perform metabolic conversions that are
essential for the host, often related to the degradation of
proteins or complex sugar polymers. The colonization of
the gastrointestinal tract with the Bacteroidetes is pro-
moted already in infants, as mother milk’s nondigestible
oligosaccharides support the growth of both Bacteroides
and Bifidobacterium spp. (Marcobal et al., 2011). Further-
more, animal model experiments have shown that the
colonization of the normal gastrointestinal tract, as illus-
trated by experiments with pure cultures of Bacteroides
spp., is a result of the recognition and selection by the
immune system of the host (Rakoff-Nahoum et al.,
2004), mediated through the toll-like receptors (Round
et al., 2011; Lopez-Siles et al., 2012) and other specific
host-microorganism interactions (Hooper et al., 2012).
For a long time, it was thought that the majority of
Gram-negative gastrointestinal tract bacteria belonged to
the Bacteroides genus, but in recent years many earlier
designed Bacteroides spp. were assigned to other genera
within the Bacteroidetes phylum. Currently, only four gas-
trointestinal Bacteroides spp. form deep branches in the
phylogenetic tree (Fig. 6), suggesting that these bacteria
(B. ureolyticus, B. galacturonicus, B. pectinophilus, and
B. coagulans) still should be reclassified to other phyloge-
netic groups. A similar situation applies to Anaerorhabdus
furcosa, which is still classified as a member of the Bacter-
oidaceae family, but based on its SSU rRNA gene
sequence clusters within the Firmicutes phylum. The
majority of the gastrointestinal Bacteroidetes spp. belongs
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Fig. 6. Phylogenetic tree of the human gastrointestinal species that belong to the class of the Bacteroidia. GenBank Accession Numbers of the
SSU rRNA gene sequence are provided for each species and the family names are indicated. Deeply rooted Bacteroides spp., which based on the
SSU rRNA gene sequence cluster within distant phylogenetic groups are depicted in the gray area.
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to the following bacterial families: Bacteroidaceae, Prevo-
tellaceae, Rikenellaceae, and Porphyromonadaceae (Fig. 6).
These bacterial species share the common feature that
they produce succinic acid, acetic acid, and in some cases
propionic acid, as the major end-products. Species
belonging to the genera Alistipes, Bacteroides, Parabactero-
ides, Prevotella, Paraprevotella, Alloprevotella, Barnesiella,
and Tannerella are saccharolytic, while species belonging
to Odoribacter and Porphyromonas are predominantly
asaccharolytic. Some Bacteroides spp. and Prevotella spp.
can degrade complex plant polysaccharides such as starch,
cellulose, xylans, and pectins (Wu et al., 1992; Morotomi
et al., 2009; Sakamoto & Ohkuma, 2012). The Bacteroide-
tes species play also an important role in protein metabo-
lism, as some species have proteolytic activity, assigned to
the proteases that are linked to the cell wall (Macfarlane
et al., 1986; Macfarlane et al., 1988), while some Bactero-
ides spp. have a potential to utilize urea as a nitrogen
source (Yatsunenko et al., 2012). Other important func-
tions of Bacteroides spp. include the deconjugation of bile
acids (Narushima et al., 2006) and growth on mucus (Le-
itch et al., 2007). The Bacteroidetes contribute to the
recently proposed classification of the gastrointestinal
microbiota into enterotypes (Arumugam et al., 2011).
The importance of the Bacteroidetes is further illustrated
by the fact that this group is the most stable component
of the gastrointestinal microbiota over time in healthy
adults (Rajilic-Stojanovic et al., 2013b). Anecdotally, a
unique case report described the microbiota of a critically
ill patient that harbored no Bacteroidetes — this patient
passed away soon after sampling (Dubourg et al., 2013).
Because of their broad metabolic potential, the role of
the Bacteroidetes in the gastrointestinal microbiota is
complex: while the reduced abundance of the Bacteroide-
tes in some cases is associated with obesity (Ley, 2010)
and irritable bowel syndrome (Rajilic-Stojanovic et al.,
2011), this bacterial group appears to be enriched in
patients suffering from type 1 and type 2 diabetes (Larsen
et al., 2010). Moreover, Bacteroides spp. in contrast to
Prevotella spp. were recently found to be enriched in the
metagenomes of subjects with low gene richness that were
associated with adiposity, insulin resistance and dyslipida-
emia as well as an inflammatory phenotype (Le Chatelier
et al., 2013).
Bacteroidetes species that belong to classes Flavobacteri-
ales and Sphingobacteriales are only occasionally detected
in the gastrointestinal tract (Fig. 7, Table S1). With an
exception of Capnocytophaga spp. and Sphingobacterium
spp. that can be detected in the human oral cavity, the
other bacteria of this group are typically associated with
other ecosystems (primarily soil). There is no data about
the role of these bacteria in the gastrointestinal microbi-
ota, but it is noteworthy that several of these bacteria
were detected only in the SSU rRNA gene clone libraries
of the microbiota of inflammatory bowel disease patients
(Frank et al., 2007).
Firmicutes
Firmicutes are the most diverse and abundant group of
the gastrointestinal microbiota, making up over half and
in many cases around 80% of the gastrointestinal micro-
biota of healthy adults. The gastrointestinal Firmicutes are
distributed over four classes: Bacilli, Clostridia, Erysipelo-
trichi, and Negativicutes. Traditionally, this group is con-

























Fig. 7. Phylogenetic tree of the human gastrointestinal species that belong to the classes of the Cytophagia and Sphingobacteria. GenBank
Accession Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated.
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content in their DNA, although recent studies have
shown that Gram-positive staining is not a feature of
many Firmicutes. This can be illustrated with Faecalibacte-
rium prausnitzii, which is a Gram-negative-staining bacte-
rium, previously classified within the Fusobacteria phylum
(Duncan et al., 2002a), novel gastrointestinal isolates such
as Christensenella minuta (Morotomi et al., 2012), but
also typical Gram-negative bacteria such as members of
the Veillonellacea family (Marchandin et al., 2010). While
the vast majority of the Firmicutes are indeed low GC
content bacteria, this also, is not a common feature of
the phylum as seen in an example of Anaerofustis ster-
corihominis, which DNA has a content of the GC of
around 70% (Finegold et al., 2004). Most of the Firmi-
cutes, notably the Clostridium spp. and Bacillus spp., are
spore-formers and this property confers special survival
value in and beyond the gastrointestinal tract.
The most abundant gastrointestinal microorganisms
are members of the class Clostridia and within this class
the families Ruminococcaceae and Lachnospiraceae (Tap
et al., 2009; Jalanka-Tuovinen et al., 2011). Another
diverse group of the Firmicutes is the class Bacilli that
includes the genera of Lactobacillus, Enterococcus, and
Streptococcus, which are dominant in the upper part of
the gastrointestinal tract. In line with its enormous diver-
sity, the Firmicutes in the gastrointestinal tract perform a
number of different functions that stretch from health
promoting of some probiotic Lactobacillus spp. to patho-
genic properties of Clostridium difficile. The vast majority
of the currently uncultured gastrointestinal inhabitants
belong to the phylum Firmicutes (Rajilic-Stojanovic et al.,
2007), which illustrates that future research is expected to
dramatically expand our knowledge about the functional
contribution of this group to the ecosystem and the host.
Bacilli
The first representative of the Bacilli class retrieved from
the gastrointestinal tract was a member of Lactobacillales
order and was isolated in 1900 — Bacillus acidophilus
(Moro, 1900). The description of this species is vague,
based on the currently accepted standards, and as the ori-
ginal strain was lost, it is not clear if this species is Lacto-
bacillus acidophilus or one of the other five species
derived from the so-called L. acidophilus group (Mits-
uoka, 1992). Lactobacilli comprise a group of gastrointes-
tinal inhabitants that has received particular scientific
attention (Tannock, 2004), mainly because of the health
claims proposed by Metchnikoff (1908) in the beginning
of the nineteenth century and their later application as
probiotics. Although highly important for the health, Lac-
tobacilli are rarely detected as markers of the gastrointes-
tinal microbiota dysbiosis, but such reports exist and
include a reduced abundance in patients suffering from
inflammatory bowel disease (Keighley et al., 1978; Ott
et al., 2004), type 1 diabetes (Murri et al., 2013). This
might be related to the fact that lactobacilli are only a
minor fraction of the fecal microbiota where they can
reach counts of up to 108 cells g1 (Simon & Gorbach,
1984), and most of the analysis of the gastrointestinal
microbiota is based on the use of stool samples. In the
small intestine Lactobacillus spp. represent one of the pre-
dominant groups obtained by culturing (Reuter, 2001).
However, while molecular studies could confirm their
presence in the upper intestinal tract, these also showed
that the Lactobacilli are quite variable and not as abun-
dant as other gastrointestinal genera at that location, such
as Streptococcus and Veillonella (Booijink, 2009; Booijink
et al., 2010). This may explain why Lactobacillus spp.
should be part of the diet, as consumed probiotic strains
of Lactobacillus spp. have a beneficial effect on human
health and specific induction of gene expression has been
observed in duodenal biopsies after exposure of Lactoba-
cillus plantarum (van Baarlen et al., 2009). Specific media,
developed already in the 1950s (Rogosa et al., 1951),
enabled the isolation of numerous Lactobacillus spp. Nev-
ertheless, new Lactobacillus spp. from human gastrointes-
tinal tract are still being reported (Roos et al., 2005; Oki
et al., 2012), indicating that even the 38 known gastroin-
testinal Lactobacillus sp. (Fig. 8) are not covering the
group’s full diversity. Several previously misclassified Lac-
tobacillus spp. have now been reclassified into novel gen-
era, including Weissella, Atopobium, Eggerthia, and
Kandleria (Collins & Wallbanks, 1992; Bjorkroth et al.,
2002; Salvetti et al., 2011). Currently, only Lactobacillus
rogosae is strongly outgrouping from the remaining Lacto-
bacillus spp., although even after exclusion of the strongly
outgrouping species, the species show a large degree of
the SSU rRNA gene variation and form several groups in
the phylogenetic tree (Fig. 8) As Lactobacillus spp. pro-
duce lactic acid as the major fermentation production
that can be accompanied with ethanol and carbon dioxide
in some species and under some conditions, traditionally
Lactobacillus spp. are classified into three groups: obli-
gately homofermentative, facultatively homofermentative,
and obligately heterofermentative. However, the phyloge-
netic position of the species does not seem to be related
to their fermentation profile.
In addition to Lactobacillus spp., other related, lactic
acid bacteria can be detected in the gastrointestinal tract.
Members of the genera Leuconostoc and Weissella used to
be considered as occasional and possibly transient mem-
bers of the gastrointestinal microbiota. However, a recent
study showed that Leuconostoc spp. and Weissella spp. are
abundant (representing up to 24% of total microbial
community) and widely distributed in colonic mucosa
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after bowel cleansing (Hong et al., 2011). Moreover, Leu-
conostoc was identified as the most abundant bacterial
genus, representing almost a quarter of the total micro-
bial community in a group of meconium samples of new-
borns, which persisted in the gastrointestinal tract until
7 months of age (Gosalbes et al., 2013). In the same
study, Weissella spp. were also detected as the earliest col-
onizers of the gastrointestinal tract of some newborns.
These bacteria utilize simple sugars and their presence in
the lower parts of the gastrointestinal tract is dependent
on the activity of other gastrointestinal microorganisms
that have the ability to degrade complex sugars, resistant
to human digestive enzymes.
Other relevant gastrointestinal bacteria belonging to the
Lactobacillales order include members of the genera Strep-
tococcus and Enterococcus. These two genera have only
recently been separated, although the presence of the sub-
group within the genus Streptococcus was noticed as late
as in the 1930s (Sherman, 1938). They are one of the
dominant bacterial fractions in the upper part of the
small intestine (Simon & Gorbach, 1986; Reuter, 2001).
Forty-six species of these two genera are known to be gas-
trointestinal inhabitants (Fig. 9). In addition, Streptococ-
cus pleomorphus, which also can be part of the
gastrointestinal microbiota, forms a deep branch in the
SSU rRNA gene sequence–based phylogenetic tree, sug-
gesting that this species should be reclassified into
another genus within the Erysipelotrichaceae family. The
ample presence of the Enterococcus and Streptococcus spp.





























































Fig. 8. Phylogenetic tree of a fraction of the human gastrointestinal species that belong to the order of the Lactobacillales. GenBank Accession
Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated. For the other gastrointestinal species
that belong to the order of the Lactobacillales see Fig. 9.
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tolerant and easily cultivable. The oldest isolate of the
group, Enterococcus faecalis, was for the first time plated
in 1899 from a case of endocarditis (MacCallum & Has-
tings, 1899), and only 7 years later it was recovered from
intestinal samples (Andrewes & Horder, 1906). Both
Streptococcus and Enterococcus spp. are among the first
established species in the infant’s gastrointestinal tract
that can be detected already in the first day of life (Solıs
et al., 2010; Gosalbes et al., 2013). Although this early
presence would suggest an important role in the ecosys-
tem, the data on the role of Streptococcus and Enterococcus
spp. in human health are conflicting. Enterococcus spp.
are widely recognized as opportunistic pathogens,
although these species are common, and can even exhibit
probiotic properties (O Cuıv et al., 2013). The abundance
of a Streptococcus species is decreased in mucosal biopsies
in Crohn’s disease patients (Li et al., 2012), while Strepto-

























































Fig. 9. Phylogenetic tree of the human gastrointestinal species that belong to the families of Streptococcaceae and Enterococcaceae. GenBank
Accession Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated. For the other
gastrointestinal species that belong to the order of the Lactobacillales see Fig. 8.
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increased in fecal samples of colorectal cancer patients
(Wang et al., 2012). However, in the adult gastrointesti-
nal tract, Streptococcus spp. are particularly abundant in
the upper part of the gastrointestinal tract, where they are
active in the process of simple sugar fermentation into
lactate (Zoetendal et al., 2012). Moreover, they may form
a tropic chain with the equally abundant Veillonella spp.
that convert the produced lactate into propionate
(Zoetendal et al., 2012).
Various members of the Bacillales order can be low-
level constituents of the human gastrointestinal microbi-
ota (Figs 10 and 11 — for clarity the phylogenetic tree of
this numerous order was split into two parts). Among
them, a large number of Staphylococcus spp., which typi-
cally are associated with the human skin, can be detected
in the human gastrointestinal tract (Fig. 11). These bacte-
ria are one of the earliest colonizers of the gastrointestinal
tract, particularly in infants that were delivered by cesar-
ean section (Dominguez-Bello et al., 2010). The predomi-
nant early colonization with Staphylococcus spp. is,
however, coupled with several health risks, as it induces
strong stimulation of the immune system, which can be a
trigger for the development of asthma and rhinitis in later
childhood (Johansson et al., 2012). Furthermore, pre-
dominant colonization of the gastrointestinal tract of pre-
mature infants with Staphylococcus spp. is associated with
fatal sepsis (Madan et al., 2012). An increased abundance
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Fig. 10. Phylogenetic tree of a fraction of the human gastrointestinal species that belong to the order of the Bacillales. GenBank Accession
Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated. The species indicated in bold are
based on the SSU rRNA gene sequence clustering within the families that are designated on the figure in contrast to their official classification.
For the other gastrointestinal species that belong to the order of the Bacillales see Fig. 11.
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Fig. 11. Phylogenetic tree of a fraction of the human gastrointestinal species that belong to the order of the Bacillales. GenBank Accession
Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated. For the other gastrointestinal species
that belong to the order of the Bacillales order see Fig. 10.
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the upper and lower gastrointestinal tract, is associated
with celiac disease, although the abundance of these bac-
teria can be depleted with the withdrawal of gluten from
the diet of patients (Collado et al., 2009).
Gemella spp. are abundant in the upper gastrointestinal
tract and specially the proximal small intestine (Ou et al.,
2009). While their function in the gastrointestinal tract
has not been determined, these species can include patho-
genic strain that translocate to other organs. For instance,
Gemella spp. have been described as likely causing agents
of endocarditis, particularly in patients that suffer from
gastrointestinal disorders (such as colon cancer; Lopez-
Dupla et al., 1996).
Numerous members of the Bacillus and Paenibacillus
genera have been detected in the samples of the human gas-
trointestinal tract. The first representatives of this group of
bacteria were isolated in 1919 by Marjorie Batchelor, who
reported Bacillus cereus as the most prevalent member of
the aerobic sporogenic bacteria in infant feces (Batchelor,
1919). Members of the Bacillus genus were often reported
in the older cultivation-based studies, but the vast majority
of the species of this genus and related genera were
reported only recently (Hoyles et al., 2012; Lagier et al.,
2012a; Zoetendal et al., 2012). One of these studies was
designed for the targeted cultivation of Bacillus and related
species from human samples (Hoyles et al., 2012). It has
been shown that Bacillus spp. could be retrieved from all
analyzed samples, although these bacteria have very low
abundance of 102–104 cells mL1 of intestinal content.
Many of the Bacillus spp. isolated in this study exhibited
notable antimicrobial activity. This feature is in line with
the use of several Bacillus spp. as potent probiotics with
immunomodulatory potential (Duc et al., 2004). Little is
known about the function of these bacteria in the ecosys-
tem, but it is noteworthy that two independent studies have
shown that members of the Bacillales order, more specifi-
cally Aneurinibacillus spp., have an increased abundance in
feces of irritable bowel syndrome patients (Krogius-
Kurikka et al., 2009; Rajilic-Stojanovic et al., 2011), while a
significantly higher abundance of Bacillus subtilis was found
in the feces of bottle-fed than breast-fed babies (Benno
et al., 1984).
Clostridia
The class Clostridia clusters bacteria that are dominant
and frequently detected in the lower gastrointestinal tract
that are distributed within the families: Clostridiaceae,
Christensenellaceae, Eubacteriaceae, Lachnospiraceae, Pepto-
streptococcaceae, Ruminococcacea as well as bacteria with
an unclear taxonomic status that are classified within
Clostridiales Incertae Sedis families XI and XIII (Garrity
et al., 2005). Members of the Clostridia class are hetero-
geneous and many of its members were initially assigned
to Clostridium genus and subsequently reclassified into
novel genera. The Clostridium sensu stricto — the real
Clostridium spp. — are grouped around the type species
Clostridium butyricum and belong to the Clostridium clus-
ter I within the Clostridiaceae family (Fig. 12; Stacke-
brandt et al., 1999). In addition to Clostridium spp., the
Clostridiaceae officially groups Sarcina spp., Butyricicoccus
pullicaecorum and Lactonifactor longoviformis, Anoxynatro-
num sibiricum while the latter three, based on their SSU
rRNA gene sequence, should be assigned to various other
Clostridiales families (Figs 13, 14 and 16). The first
human gastrointestinal Clostridium isolate, C. perfringens,
was recovered in 1905 (Passini, 1905). The same species,
previously known as Bacillus aerogenes capsulatus and
Clostridium welchii, was earlier isolated from a case of
endocarditis (Welch & Nuttall, 1892). Both isolation sites
fit the nowadays known properties of C. perfringens,
which is a commensal gastrointestinal bacterium that can
cause bacteraemia (Petit et al., 1999). Up to now, 72
Clostridium spp. have been detected in the human gastro-
intestinal samples, of which 30 belong to the Clostridium
sensu stricto (Fig. 12). The other Clostridium spp. belong
to different families within the Firmicutes phylum, while
Clostridium rectum belongs to the Fusobacteria phylum.
Members of the Clostridium sensu stricto are generally
perceived as pathogenic, although cultivation-based stud-
ies show that C. perfringens and other real clostridia can
be found in densities of up to 1010 cells g1 intestinal
content of healthy individuals (Finegold et al., 1974), and
up 107 cells g1 intestinal content of healthy infants
(Mevissen-Verhage et al., 1987). Still, the presence of
these bacteria, notably as seen for C. perfringens in elderly
Irish subjects, is interpreted as an indicator of a less
healthy microbiota (Lakshminarayanan et al., 2013).
The most abundant and diverse gastrointestinal family
is the Lachnospiraceae. This family groups 24 different
genera, most of which can be detected in the human gas-
trointestinal tract. In addition, a number of species that
are officially classified into the genera Clostridium, Eubac-
terium, and Ruminococcus, cluster within the Lachnospira-
ceae based on their SSU rRNA gene sequence (Fig. 13).
Members of the Lachnospiraceae are also among the first
to be established in the gastrointestinal tract. A recent
study showed that Ruminococcus gnavus is an exclusive
representative of this family in 2-months old breast-fed
infants, while infants fed with cow-milk based formula
have a more diverse Lachnospiraceae community (Tan-
nock et al., 2013). Analysis of the microbiota of children
and adults showed that this group of bacteria is predomi-
nant in both young children and in adults, which indicates
the early establishment of these bacteria (Ringel-Kulka
et al., 2013).
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Several members of the Lachnospiraceae family are
butyrate producers including Anaerostipes spp., Butyrivib-
rio spp., Coprococcus spp., Roseburia spp., Eubacterium
rectale- and Eubacterium hallii-related species. Butyrate
can be used as an energy source by the gut epithelial cells,
and it has anticarcinogenic and anti-inflammatory prop-
erties (Hamer et al., 2008). Furthermore, a recent study
shows that butyrate produced by intestinal microorgan-
isms has beneficial effects on glucose and energy homeo-
stasis (De Vadder et al., 2014). The decrease in the
relative abundance of the butyrate-producing Lachnospir-
aceae in the gastrointestinal microbiota is associated with
compromised health status of subjects suffering from
colorectal cancer (Wang et al., 2012), ulcerative colitis
(Rajilic-Stojanovic et al., 2013a), type 1 (Murri et al.,
2013) and type 2 diabetes (Qin et al., 2012). This bacte-
rial group seems to be stimulated by an omnivore diet,
since it is present in lower abundance in vegetarians
(Kabeerdoss et al., 2012). This is an intriguing but not
yet explained finding, as it could be expected that vege-
tarian, plant-based diets, which are rich in fibers, would
favor butyrate production in the colon and promote
health.
The gastrointestinal Lachnospiraceae include Dorea spp.,
which are the major gas producers in the gastrointestinal
tract and its end-products of glucose fermentation include
both hydrogen and carbon dioxide (Taras et al., 2002).
Dorea spp. were found in an increased in abundance in
both pediatric and adult irritable bowel syndrome
patients (Rajilic-Stojanovic et al., 2011; Saulnier et al.,
2011), which probably could explain the symptom of


















































Fig. 12. Phylogenetic tree the human gastrointestinal species that belong to the family of Clostridiaceae. GenBank Accession Numbers of the
SSU rRNA gene sequence are provided for each species and the family names are indicated. The species indicated in bold are based on the SSU
rRNA gene sequence clustering within the families that are designated on the figure in contrast to their official classification. Deeply rooted
Clostridium spp., which based on the SSU rRNA gene sequence cluster within distant phylogenetic groups, are depicted in the gray area.
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Fig. 13. Phylogenetic tree the human gastrointestinal species that belong to the family of the Lachnospiraceae. GenBank Accession Numbers of
the SSU rRNA gene sequence are provided for each species and the family names are indicated. The species indicated in bold are based on the
SSU rRNA gene sequence clustering within the families that are designated on the figure in contrast to their official classification.
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Blautia is a recently described bacterial genus that
groups several abundant gastrointestinal bacteria that
were previously assigned to the Ruminococcus genus –
notably those related to Ruminococcus obeum (Fig. 14).
The common feature of Blautia spp. is the utilization of
hydrogen and carbon dioxide to form acetate (Bernalier
et al., 1996). Blautia spp. are among the most abundant
members of the entire gastrointestinal tract and can
encompass between 2.5% and 16% of the total microbi-
ota (Zoetendal et al., 2002). This abundant bacterial
group is significantly depleted in elderly subjects (Hayashi
et al., 2003; Biagi et al., 2010) and in mucosal samples of
colorectal cancer patients (Chen et al., 2012). In contrast,
increased levels of Blautia spp. are observed in irritable
bowel syndrome patients (Rajilic-Stojanovic et al., 2011),
but this could reflect the adaption of the ecosystem to
the larger amount of gasses produced by Dorea spp.,
which can be utilized by Blautia spp.
An interesting group within the Lachnospiraceae family
is the misclassified Ruminococcus spp., including R. gna-
vus, R. torques, R. lactaris, and R. faecis. These bacteria
are abundant in the gastrointestinal tract (Holdeman &
Moore, 1974), and apparently associated with a number
of important metabolic functions. R. torques and other
currently uncultured species related to R. torques, are
among the most potent mucus utilizes that enable mucus
degradation by secretion of several different extracellular
glycosidases (Hoskins et al., 1985). Furthermore, the
abundance of these bacteria is strongly associated with
the level of triglycerides in blood serum (Lahti et al.,
2013). Several studies of the microbiota of irritable bowel
syndrome patients and controls have shown that organ-
isms related to these misclassified Ruminococcus spp. are
significantly elevated in patients (Kassinen et al., 2007;
Rajilic-Stojanovic et al., 2011; Saulnier et al., 2011).
Moreover, the abundance of these bacteria is positively
correlated with irritable bowel syndrome symptoms (Mal-
inen et al., 2010) and significantly reduced by probiotics
consumption that reduces these symptoms (Lyra et al.,
2010).
The Ruminococcaceae family is another relevant group
of gastrointestinal bacteria within the Clostridiales order.
It includes the true Ruminococcus spp. — members of the
Ruminococcus sensu stricto namely R. albus, R. bromii,
R. callidus, R. champanellensis, and R. flavefaciens. Several


































Fig. 14. Phylogenetic tree the human gastrointestinal species that belong to the Clostridium cluster IV, most of which belong to the family of
the Ruminococcaceae. GenBank Accession Numbers of the SSU rRNA gene sequence are provided for each species and the family names are
indicated. The species indicated in bold are based on the SSU rRNA gene sequence clustering within the families that are designated on the
figure in contrast to their official classification. Deeply rooted Ruminococcus spp., which based on the SSU rRNA gene sequence cluster within
distant phylogenetic groups, are depicted in the gray area.
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recognized members of the Clostridium cluster IV (Clos-
tridium leptum group) are either members or are closely
related to this family (Fig. 14). The true Ruminococcus
spp. are an abundant fraction of the human gastrointesti-
nal microbiota that can reach densities of up to
1010 cells g1 of intestinal content (Finegold et al., 1977).
Being strictly anaerobic cellulolytic cocci, Ruminococcus
spp. were isolated from human gastrointestinal samples
only after the improvement of the anaerobic techniques
and media for studying rumen anaerobes (Hungate,
1947). The first human gastrointestinal Ruminococcus spp.
reported is Ruminococcus bromii isolated in 1972 (Moore
et al., 1972). Similar to the other gastrointestinal bacteria,
the initially defined Ruminococcus spp. are a heteroge-
neous group, which based on the SSU rRNA gene
sequence clusters within the Ruminococcaceae and Lachno-
spiraceae families. Recently, five gastrointestinal Rumino-
coccus spp. were reclassified into Blautia genus, leaving
seven others to be reclassified (Liu et al., 2008; Figs 9 and
10). Bacteria that belong to the Ruminococcus sensu stricto
degrade complex sugars to produce acetate as the major
fermentation product. Both in vitro and in vivo studies
have shown that R. bromii is the major degrader of the
resistant starch in the human gastrointestinal tract (Ko-
vatcheva-Datchary et al., 2009; Walker et al., 2011).
Application of the resistant starch in the diet has a wide
range of health-promoting effects, suggesting the impor-
tance of the metabolic activity of R. bromii for the wellbe-
ing of the host (Higgins & Brown, 2013). The importance
of the members of the Ruminococcus sensu stricto for the
intestinal health is indicated by their reduced abundance
in feces of Crohn’s disease (Kang et al., 2010) and ulcera-
tive colitis patients (Rajilic-Stojanovic et al., 2013a).
Among the Ruminococcaceae family, Faecalibacterium
prausnitzii (previously known as Fusobacterium prausnitzii)
is the most prevalent and abundant gastrointestinal micro-
organism (Holdeman et al., 1976). Faecalibacterium
prausnitzii can utilize glucose, fructose, and fructo-oligosa-
charides, as well as complex molecules such as pectin and
N-acetylglucosamine to produce butyrate, formate and lac-
tate (Duncan et al., 2002a; Lopez-Siles et al., 2012). It is
one of the major butyrate producers in the gastrointestinal
tract, which is a relevant feature because of the health-pro-
moting properties of butyrate. The reduced abundance of
this bacterium is detected in association with Crohn’s dis-
ease (Sokol et al., 2006; Kang et al., 2010) and with colon
cancer (Chen et al., 2012). This bacterium is important for
the gastrointestinal microbiota homeostasis as it has found
to show anti-inflammatory properties in mice (Sokol et al.,
2008) and is associated with a range of metabolic processes
in the human mucosa (Lepage et al., 2011). Health-pro-
moting properties are also exhibited by B. pullicaecorum,
another species with the SSU rRNA gene sequence that is
related to the Ruminococcaceae family. This bacterium is
significantly reduced in inflammatory bowel disease
patients, while its oral administration strengthens the epi-
thelial barrier function in animal models by increasing the
trans-epithelial resistance (Eeckhaut et al., 2013).
The first Eubacterium spp. from a human gastrointesti-
nal sample was isolated already in 1908 when Henri Tis-
sier plated Bacillus ventriousus, later renamed into
Eubacterium ventriosum (Tissier, 1908). The genus Eubac-
terium was for a long time recognized as one of the most
abundant genera of the human gastrointestinal microbi-
ota, with densities of up to 1010 cells g1 of intestinal
content (Moore & Holdeman, 1974a). However, Eubacte-
rium, similar to Clostridium, is a genus that is very
vaguely described. Defined as anaerobic, rod-shaped,
Gram-positive bacteria that do not form endospores,
Eubacterium genus includes a consortium of distantly
related species. Some Eubacterium spp. have been reclassi-
fied into novel genera within two bacterial phyla —
Actinobacteria and Firmicutes — of which six genera
(Dorea, Collinsella, Eggerthella, Flavonifractor, Mogibacteri-
um and Pseuodramibacter) can be members of the gastro-
intestinal microbiota (Willems & Collins, 1996; Kageyama
et al., 1999a, b; Nakazawa et al., 2000; Taras et al., 2002;
Carlier et al., 2010). Further reclassification of the genus
can be expected, as only four gastrointestinal Eubacterium
spp. belong to the Eubacterium sensu stricto (Fig. 15). In
a recent study of the gastrointestinal microbiota of cente-
narians, Eubacterium spp. (notably those related to Eubac-
terium limosum) were reported as signature bacteria of
the long life, being 10-fold increased in centenarians
(Biagi et al., 2010). It is known that E. limosum has the
ability to transform dietary phytoestrogens into forms
that might have a positive impact on health (Clavel et al.,
2006; Possemiers & Verstraete, 2009). Furthermore,
E. limosum is selectively stimulated by prebiotics that
improve the symptoms of inflammatory bowel disease
patients (Kanauchi et al., 2005).
Mogibacterium is a genus established by reclassification
of the intestinal bacterium – Eubacterium timidum. Mogi-
bacterium spp. are enriched in mucosa-associated micro-
biota in colon cancer patients but not much is known
about this group of bacteria belonging to Clostridium
Family XIII Incertae Sedis (Chen et al., 2012).
Prior to the molecular revolution of the gastrointestinal
microbiota research (Fig. 1), Peptococcus spp. and Pepto-
streptococcus spp. were considered as the dominant and
abundant in the human gastrointestinal tract (Holdeman
et al., 1976). However, the latter research has shown that
these two genera are heterogeneous and led to the major
reclassification resulting in definition of novel genera that
include Anaerococcus, Blautia, Finegoldia, Parvimonas, and
Peptoniphilus (Murdoch & Shah, 1999; Ezaki et al., 2001;
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Tindall & Euzeby, 2006; Liu et al., 2008). All these genera,
with exception of Blautia that is a genus in the Lachno-
spiraceae family, belong to the Clostridiales Family XI
Incertae Sedis (Fig. 16). Among this group of bacteria,
Peptoniphilus asaccharolyticus is the most frequently
detected and also was the first to be cultured and
described (Distaso, 1911). Currently, only two true Pepto-
streptococcus spp. have been recognized as gastrointestinal
inhabitants, although a number of other species that are
officially classified within different genera (predominantly
Clostridium) belong to the Peptostreptococcaceae family
according to their SSU rRNA gene sequence (Fig. 16).
Members of the Peptostreptococcaceae family are, in prin-
ciple, associated with compromised health, and the most
convincing example of this is Clostridium difficile.
Although C. difficile can be present in low numbers in
healthy subjects without exhibiting pathogenic properties
(Ozaki et al., 2004), many strains are toxin producing
and are well-established pathogens that cause severe diar-
rhea. Furthermore, recent studies have shown that Pepto-
streptococcus spp. have an increased abundance in
association with ulcerative colitis (Rajilic-Stojanovic et al.,
2013a) and colorectal cancer (Chen et al., 2012; Wang
et al., 2012). Based on the SSU rRNA gene sequence, the
members of the Peptococcaceae family form two paraphy-
letic groups within the Firmicutes phylum, of which the
group that contains the two human gastrointestinal bacte-
ria is closely related to Negativicutes class and is discussed
in the following section.
In addition to the already mentioned species, five other
gastrointestinal bacteria that officially belong to the Clo-
stridia class, form distinct branches in the phylogenetic
tree (Fig. 17). Two of these gastrointestinal bacteria,
namely Catabacter hongkongensis and C. minuta, form a
separate cluster within the Clostridiales order of the
Clostridia class and are the only cultured representatives
of a phylogenetic group that was previously detected only
in various molecular studies and was in a previous review
designated as uncultured Clostridiales II (Rajilic-Stojano-
vic et al., 2007). These two species are officially assigned
to two different families (Catabacteriaceae and Christense-
nellaceae), although based on the SSU rRNA gene
sequence similarity (96.5%), they should be grouped in
the same family, and, most likely, in the same genus.
Catabacter hongkongensis was isolated in 2007 from a
blood sample, although the intestinal origin of the bacte-
rium was suspected (Lau et al., 2007). This bacterium
was later isolated from patients with acute appendicitis,
but also from other tissues where it was a causative agent
of fatal bacteremia (Lau et al., 2012). Christensenella min-
uta is an intestinal isolate, described in 2012 (Morotomi
et al., 2012). Not much is known about the role of this
group of strictly anaerobic bacteria in the human gastro-
intestinal tract, but it is noteworthy that bacteria that
belong to the Christensenella/Catabacter group were
reported to be dramatically (20-fold) depleted in fecal
samples of ulcerative patients relative to controls (Rajilic-
Stojanovic et al., 2013a) and significantly (fivefold)
depleted in fecal samples of patients with postinfectious
irritable bowel syndrome (Jalanka-Tuovinen et al., 2013).
Two members of the Peptococcaceae family were
reported as members of the human gastrointestinal
Lachnospiraceae (cluster XIVa)
Ruminococcaceae (cluster IV)
























Fig. 15. Phylogenetic tree the human gastrointestinal species that belong to the family of the Eubacteriaceae and Clostridiales Family XIII
Incertae Sedis. GenBank Accession Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated.
The species indicated in bold are based on the SSU rRNA gene sequence clustering within the families that are designated on the figure in
contrast to their official classification. Deeply rooted Eubacterium spp., which based on the SSU rRNA gene sequence cluster within distant
phylogenetic groups are depicted in the gray area.
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microbiota (Fig. 17). These bacteria are officially classified
within the Clostridia class and Clostridiales order,
although based on the SSU rRNA gene sequence they are
closely related to the members of the Selenomonadales
order within the Negativicutes class (Fig. 18). Based on
their SSU rRNA gene sequence, gastrointestinal members
of the Peptococcaceae family will be reclassified either the







































Fig. 16. Phylogenetic tree the human gastrointestinal species that belong to families of the Peptostreptococcaceae and Clostridiales Family XI
Incertae Sedis. GenBank Accession Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated.
The species indicated in bold are based on the SSU rRNA gene sequence clustering within the families that are designated on the figure in
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Fig. 17. Partially opened phylogenetic tree
the human gastrointestinal species that belong
to the Firmicutes phylum on which five species
that cluster within the three families with low
diversity are indicated.
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from Clostridia sensu stricto. Peptococcus niger is the only
representative of the genus. This strictly anaerobic bacte-
rium has been isolated from various body sites, while the
strain isolated from feces showed an ability to desulfate
and perform other chemical transformation of steroid
molecules (Van Eldere et al., 1987). This feature of
P. niger makes it an important player in enterophatic cir-
culation of various steroid molecules, primarily steroid
hormones, which has a major impact on human metabo-
lism. Another member of the Peptococcaceae family, Des-
ulfitobacterium hafniense, has been reported only once as
an inhabitant of the human gastrointestinal tract (van de
Pas et al., 2001). In contrast to other members of the
genus, the human D. hafniense is not able to use chloro-
ethenes or chlorophenol as terminal electron acceptors
(Smidt & de Vos, 2004). This bacterium is capable of
using sulfite as terminal electron acceptor and hence pro-
duces hydrogen sulfide. Hydrogen sulfide is also produced
by P. niger (Wilkins et al., 1975), and this property that
may be detrimental to health as described below for the
Deltaproteobacteria.
Finally, Halanaerobaculum tunisiense has been identified
by pyrosequencing of the V6 variable region of the SSU
rRNA gene in a recent study that compared efficiency of
culturomics and pyrosequencing approach for studying
the gastrointestinal microbiota diversity (Lagier et al.,
2012a). Halanaerobaculum tunisiense is a recently
described anaerobic bacterium that was isolated from
hypersaline lake in Tunisia (Hedi et al., 2009). Given the
conditions that the isolated strain of this bacterium
requires for its growth (the minimal required NaCl con-
centration of 14%), it is not likely that it represents a
member of the gastrointestinal microbiota, although this
should be confirmed in further studies.
Negativicutes
The Negativicutes include bacteria that were previously
assigned to the Clostridium cluster IX (Collins et al.,
1994; Marchandin et al., 2010), distributed within the fol-
lowing genera: Acidamoinococcus, Dialister, Megamonas,
Megasphaera, Phascolarctobacterium and Veillonella
(Fig. 18). Bacteria of this group used to be classified
within the order Clostridiales, although based on their
SSU rRNA gene sequence, they are distant from other
Clostridiales. Therefore, following the description of a
novel gastrointestinal inhabitant — Negativicoccus succi-
nicivorans, the novel class of Negativicutes and novel
order of Selenomonadales were introduced to accommo-
date the Gram-negative staining bacteria within the Fir-
micutes phylum (Marchandin et al., 2010). The first
record of this bacterial group dates from 1898 when Veil-
lon and Zuber isolated Staphylococcus parvulus, which was
later reclassified as Veillonella parvula, from infected
appendix tissue (Veillon & Zuber, 1898). The Negativi-
cutes are typically isolated from the oral cavity or the
proximal small bowel (Rogosa, 1965; Simon & Gorbach,
1986), but representative species from this group can be
detected in high abundances even in the lower intestinal
tract. In that line V. parvula, can reach densities of up to
1011 cells g1 of feces (Finegold et al., 1977), while
























Fig. 18. Phylogenetic tree the human gastrointestinal species that belong to the order of the Negativicutes. GenBank Accession Numbers of the
SSU rRNA gene sequence are provided for each species and the family names are indicated.
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showed that these bacteria represent more than 2% of the
total fecal microbiota in some subjects (Paliy et al.,
2009). Members of the Negativicutes are assacharolytic
and utilize end=products of sugar metabolisms of other
gastrointestinal bacteria (such as lactate or succinate) to
produce propionate, forming an important trophic chain.
Propionate is a beneficial product of the gastrointestinal
microbiota as it has anti-inflammatory potential, is uti-
lized by adipose tissue and the liver, plays a role in the
satiety sensation, influences glucose and energy homeosta-
sis, and improves insulin sensitivity (Vipperla & O’Keefe,
2012; De Vadder et al., 2014). In the upper gastrointesti-
nal tract, Veillonella spp. are an indispensable component
of the gastrointestinal microbiota (van den Bogert et al.,
2011) where they form a trophic chain with the lactate
and acetate-producing Streptococcus spp. (Zoetendal et al.,
2012). Currently, there is no evidence about the role of
Veillonella spp. in human health, although several studies
have shown an increased abundance of Veillonella spp. in
fecal samples of irritable bowel patients (Malinen et al.,
2005; Tana et al., 2010; Saulnier et al., 2011), which could
indicate an increased transit of the ileal microbiota to the
lower part of the gastrointestinal tract.
Erysipelotrichi
The Erysipelotrichi constitute a class of bacteria within the
Firmicutes phylum that was introduced into bacterial sys-
tematics in 2009, to accommodate members of earlier
established family Erysipelotrichaceae (Ludwig et al.,
2009). The majority of the human gastrointestinal bacte-
ria that based on their SSU rRNA gene sequence cluster
within the Erysipelotrichi class are still officially classified
within other groups of the Firmicutes (Fig. 19). This indi-
cates that a major revision of this group can be expected
in the future. There are several studies that link Erysipelo-
trichi with compromised health. An increased abundance
of Erysipelotrichi in patients suffering from colon cancer
was reported (Chen et al., 2012). Animal model experi-
ments have shown that members of this group are
increased on high fat, and western type diets (Turnbaugh
et al., 2009; Fleissner et al., 2010), while their increased
abundance is associated with obesity (Turnbaugh et al.,
2006). Furthermore, it has been shown that an increased
abundance of Erysipelotrichaceae correlates with choline
deficiency-induced fatty liver disease (Spencer et al.,
2011), which causes multiple organ dysfunctions. Choline
is an important component of our diet, and recently, it
was found that choline and phospatidylcholine are con-
verted by the intestinal microbiota to trimethylamine,
which is further metabolized to proatherogenic trimethyl-
amine-N-oxide, linking diet and microbiota to cardiovas-
cular disease (Wang et al., 2011b; Koeth et al., 2013).
Tenericutes
Tenericutes is a recently introduced phylum that accom-
modates the Mollicutes class, which was previously posi-
tioned within the Firmicutes phylum. The assignment of
the Mollicutes to the novel phylum was supported by the
unique properties of these bacteria, in particular the lack




































Fig. 19. Phylogenetic tree the human gastrointestinal species that belong to the order of the Erysipelotrichi. GenBank Accession Numbers of the
SSU rRNA gene sequence are provided for each species, while the family is divided over Clostridium clusters (Collins et al., 1994). The species
indicated in bold are based on the SSU rRNA gene sequence clustering within the Erysipelotrichi in contrast to their official classification.
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on the SSU rRNA gene sequence, they are interrelated
with the members of the Erysipelotrichi class of the Firmi-
cutes (Fig. 19). The majority of the gastrointestinal Ten-
ericutes are currently uncultured species that are
frequently detected in the molecular surveys. Their detec-
tion even in the studies of the limited depth suggests a
relatively high relative abundance of these bacteria (see
for instance, Suau et al., 1999). Concerning their function
in the gastrointestinal tract, a recent study has shown a
significant positive correlation between the abundance of
the Tenericutes and the levels of trimethylamine-N-oxide,
which is a metabolite that is believed to accelerate athero-
sclerosis (Koeth et al., 2013).
It has been suggested that members of the Tenericutes
are involved in inflammatory bowel disease, as they have
the ability to adhere to and to fuse with epithelial and
immune system cells, which could explain intracellular
epithelial structures in the Crohn’s disease patients’ biop-
sies detected by electron microscopy (Roediger & Macfar-
lane, 2002). A molecular survey has revealed that a
cultured representative of this group — the pathogenic
Mycoplasma pneumoniae — can be detected in mucosal
biopsies of both inflammatory bowel disease patients and
healthy controls alike, although Crohn’s disease patients
had a significantly higher abundance of this bacterium
than ulcerative colitis patients and healthy subjects (Chen
et al., 2001). The first report of the Mycoplasma in the
human gastrointestinal tract dates from 1973 (Bhat et al.,
1973), while specific searches for Ureaplasma urealyticum
and Mycoplasma hominis revealed the presence of these
two species in anal swaps of more than half of the ana-
lyzed subjects (Munday et al., 1981).
Fusobacteria
Fusobacteria are another phylum of the frequently
detected gastrointestinal bacteria, the majority of which
belong to the genus Fusobacterium (Fig. 20). These bacte-
ria are pointed, nonsporulating, Gram-negative, anaerobic
bacilli (Knorr, 1922). The first record of a Fusobacterium
spp. originates from 1886 when Bacillus fusiforme (now
known as Fusobacterium necrophorum) was reported as a
pathogen related to appendicitis (Fl€ugge, 1886). Although
Fusobacterium spp. can be isolated from gastrointestinal
samples of healthy humans in densities of up to
1010 cells g1 of feces (Benno et al., 1989), this group of
bacteria seems to be relevant for intestinal inflammation.
Recent studies have shown that the majority of cases of
acute appendicitis are associated with a local infection of
Fusobacterium spp. (Swidsinski et al., 2011), while the
increased abundance of Fusobacterium spp. is associated
with ulcerative colitis (Rajilic-Stojanovic et al., 2013a)
and colorectal cancer (Castellarin et al., 2012; Kostic
et al., 2012). The human gastrointestinal tract-associated
Fusobacteria also include representatives of the Leptotri-
chia genus and the misclassified C. rectum (Fig. 20).
Proteobacteria
Bacteria belonging to the phylum Proteobacteria are com-
monly detected in the gastrointestinal samples and this
group of the true Gram-negative bacteria is particularly
diverse, although not very abundant – typically all
Proteobacteria account about 1% of the total microbiota
(Holdeman et al., 1976). Members of five different classes
of Proteobacteria, namely the Alpha-, Beta-, Gamma-,
Delta- and Epsilonproteobacteria can be part of the gastro-
intestinal microbiota, and among them Enterobacteriaceae
within Gammaproteobacteria are the most abundant and
the prevalent group.
Alphaproteobacteria
Gemmiger formicilis was the first and the only bacterium
from the Alphaproteobacteria class that was associated

















Fig. 20. Phylogenetic tree the human gastrointestinal species that belong to the phylum of the Fusobacteria. GenBank Accession Numbers of
the SSU rRNA gene sequence are provided for each species and the family names are indicated. The species indicated in bold are based on the
SSU rRNA gene sequence clustering within the families that are designated on the figure in contrast to their official classification.
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20th century (Holdeman et al., 1976; Benno et al., 1986;
Moore & Moore, 1995; Macfarlane et al., 2004). Ironi-
cally, the recent SSU rRNA gene sequence analysis of
G. formicilis indicated that this species has been misclassi-
fied and belongs to Firmicutes (Clostridia/Clostridiales/
Ruminococcaceae) and has almost an identical SSU rRNA
gene sequence as Subdoligranulum variabile (98.3%
sequence similarity). Nevertheless, other representatives of
the true Alphaproteobacteria seem to be a part of the
normal gastrointestinal microbiota. In a recent study, four
alphaproteobacterial species were cultivated from gastro-
intestinal samples (Lagier et al., 2012a). Twenty-four
other members of this subdivision were detected by
retrieving SSU rRNA gene sequences identical to previ-
ously cultured bacteria from gastrointestinal samples
(Fig. 21, Table S1). AlphapProteobacteria seem to be char-
acteristic for the upper part of the gastrointestinal tract as
sequences of these bacteria were detected only in studies
where samples from the upper intestine were included
(Eckburg et al., 2005; Wang et al., 2005), or when the
microbiota of patients with ileal pouch was analyzed
(McLaughlin et al., 2010). There are no data that corre-
late Alphaproteobacteria with any specific function in the
gastrointestinal tract or any disease. However, some
genera are known to perform specific metabolic transfor-
mations — for example, Methylobacterium spp. include
bacteria that can oxidize methylamine or methanol to
generate energy. Although the metabolism of these com-
pounds has not been studied in the gastrointestinal tract,
and the methylotrophic community is not typically asso-
ciated with the human body, a recent study has demon-
strated that methanotrophs are ubiquitous in the human
oral microbiota (Hung et al., 2011). Similarly, it can be
anticipated that they are present in the upper gastrointes-
tinal tract, where SSU rRNA gene sequences of these bac-
teria were detected, and where oxygen needed for their
metabolic activity is present. Sphingomonas spp. include
metabolically versatile aerobic bacteria that can be found
in different environments. Studies of these and most
other Alphaproteobacteria focus on outbreaks of infections
involving these bacteria in immuno-suppressed patients.
However, animal models studies have shown that
Sphingomonas spp. are important for the development of
the immune system of the host, since these species can
stimulate the maturation of invariant natural killer T cells
(Wingender et al., 2012).
Betaproteobacteria
The first bacterium from the Betaproteobacteria class —
Alcaligenes faecalis — was isolated from a human fecal
sample in 1896 (Petruschky, 1896). This asaccharolytic
rod that can utilize urea, a range of amino-acids, and can



















































Fig. 21. Phylogenetic tree the human gastrointestinal species that belong to the class of the Alphaproteobacteria class. GenBank Accession
Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated.
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quently been detected in later studies of the gastrointesti-
nal microbiota. A number of other bacteria within this
class have been detected in recent years, showing that
Betaproteobacteria are diverse and ubiquitous members of
the gastrointestinal microbiota (Fig. 22). Among them,
Sutterella and Parrasutterella are the most frequently
encountered and the abundant gastrointestinal microor-
ganisms (Nagai et al., 2009; Mukhopadhya et al., 2011).
These bacteria are typical for the gastrointestinal microbi-
ota ecosystem, assacharolytic and inactive in classical
microbiological tests. Their abundance is increased in
autistic children (Williams et al., 2012) and in patients
suffering from type 2 diabetes (Larsen et al., 2010).
Hence, it is of interest to define which metabolic transfor-
mations are catalyzed by these bacteria, as they might be
particularly relevant for understanding the global impact
of the gastrointestinal microbiota on human health. Alca-
ligenes faecalis and related bacteria are common gastroin-
testinal tract inhabitants, notably of the ileum. Alcaligenes
spp. may be opportunists that inhabit Peyers’ patches and
signal to the immune system as shown in model animals
(Obata et al., 2010). Moreover, Alcaligenes spp. produce
NO, which is an important biological regulator (Culotta
& Koshland, 1992; Anderson et al., 1993).
Oxalobacter formigenes is another relevant intestinal
inhabitant. It has been isolated in 1985 and described as a
unique intestinal bacterium that degrades exclusively oxa-
late and can reach densities of up to 107 cells g1 of feces
(Allison et al., 1985). Due to its metabolic activity, O. for-
migenes regulates oxalate concentrations in feces and
urine, and indirectly influences the formation of kidney
stones (Duncan et al., 2002b). This has led to its applica-
tion in probiotic formulations. Recently, it has been
shown that some strains of another intestinal inhabitant
Ancylobacter polymorphus (belonging to the Alphaproteo-
bacteria) can utilize oxalate (Lang et al., 2008), suggesting
that there are alternative pathways for oxalate removal
from the gastrointestinal tract.
Neisseria spp. are inhabiting mucosal surfaces of the gen-
ital, the respiratory and the upper gastrointestinal tract.
Neisseria gonorhhoea and Neisseria meningitis are the most
studied as they are important pathogens causing gonor-
rhoea and meningitis. However, the majority of Neisseria
spp. are nonpathogenic and their presence in the gastroin-
testinal tract samples was detected in the early cultivation-
based studies (Gray & Shiner, 1967; Bhat et al., 1980). The
presence of specific Neisseria spp. in the gastrointestinal
tract was only recently reported in a high-throughput cul-
turing study (Lagier et al., 2012a) and emerged from SSU
rRNA gene sequencing-based studies (Fig. 22, Table S1).
Nonpathogenic Neisseria spp. do not catabolize many car-
bohydrates, while some species are even asaccharolytic, but
they can reduce nitrate. It is known that Neisseria spp. are
able to grow on amino acids and can use sulfur directly
from sulfate (McDonald & Johnson, 1975), but their func-
tion in the gastrointestinal tract has not been exploited.
The human gastrointestinal Betaproteobacteria also















































Fig. 22. Phylogenetic tree the human
gastrointestinal species that belong to the
class of the Betaproteobacteria. GenBank
Accession Numbers of the SSU rRNA gene
sequence are provided for each species and
the family names are indicated.
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which are occasionally reported as members of the gastro-
intestinal microbiota (Fig. 22). Among them, Acidovorax
spp. were found to be ubiquitously present in the colonic
mucosa (Hong et al., 2011), Burkholderia spp. were found
in an increased abundance in hepatic encephalopathy and
were linked to poor cognition and inflammation (Bajaj
et al., 2012), while Variovorax spp. seem to be particularly
abundant in the upper gastrointestinal tract (van den
Bogert et al., 2011). There is no available information
about association of other species with specific gastroin-
testinal sites, diseases or functions of the gastrointestinal
microbiota.
Gammaproteobacteria
Within the class Gammaproteobacteria, nine different fam-
ilies distributed within six different orders have been
detected in the human gastrointestinal samples. Escherichia
coli was the first bacterial isolate of the Gammaproteobac-
teria characterized from human gastrointestinal samples in
1885 (Shulman et al., 2007). Escherichia coli belongs to the
Enterobacteriaceae family, which is the most diverse, pre-
valent and abundant of all gastrointestinal Proteobacteria
(Fig. 23). Most of Enterobacteriaceae members are associ-
ated with diarrhea (Thielman & Guerrant, 2004), although
representatives of this family are not necessarily causing
any symptoms and are actually one of the first to be found
in the newborn gastrointestinal tract (Favier et al., 2002).
The abundance of this bacterial group increases with age,
but it remains subdominant and in elderly subjects repre-
sents about 1% of the total gastrointestinal microbiota
(Hopkins et al., 2001). Escherichia coli is the most preva-
lent representative of this family that is often the most
abundant facultative anaerobe in the gastrointestinal sam-
ples. The different strains of E. coli can exhibit different
properties, varying from probiotic (Kruis et al., 2004) to
pathogenic causing diarrhea or infections on other sites
(Ron, 2006). The majority of other Enterobacteriaceae spp.
are infrequently isolated from gastrointestinal samples
(Bucher & von Graevenitz, 1982; M€uller, 1986). In that
line, a study of dedicated isolation of the Morganella-
Proteus-Providencia group from feces of almost 3000
healthy subjects and patients suffering from enteric dis-
eases, showed that species of this group are subabundant
and have joined prevalence between 10% and 20%,
depending on the health status (M€uller, 1986). Still, the
Enterobacteriaceae is one of the most comprehensively
described gastrointestinal families, which can be explained
by its development as a paradigm for genetic studies and
its clinical relevance (Grimont et al., 1981; Hickman-Bren-
ner et al., 1984; Farmer et al., 1985; Hickman-Brenner
et al., 1985a, b). A specific case is represented by the
so-called adherent-invasive E. coli strains that have been
implied in various forms of inflammation in the gastroin-
testinal tract of human and animal models (Negroni et al.,
2012; Chassaing et al., 2014). Phylogenetically, the Entero-
bacteriaceae is a diverse group and while some genera
form separate clusters (e.g., Yersinia), species of other
genera are mixed up in the SSU rRNA phylogenetic tree
(Fig. 23). The absence of genus-specific SSU rRNA gene
sequences for these genera, could explain a recent the
finding that sequences assigned to E. coli, Salmonella
enterica, Citrobacter koseri, and Enterobacter cancerogenus
appear together (Lozupone et al., 2012).
In addition to the Enterobacteriaceae, representatives of
eight other bacterial families with the Gammaproteobac-
teria class can be detected in the human gastrointestinal
tract (Fig. 24). Among these, members of the Moraxella-
ceae are relatively frequently detected using both cultiva-
tion-based and molecular studies. Within this family,
Acinetobacter spp. are the most diverse and are frequently
detected in infants (Chang et al., 2011; Pandey et al.,
2012), with an increased abundance in infants that
develop allergy (Nakayama et al., 2011). A recent study
has indicated that members of the Gammaproteobacteria
and in particular Haemophilus spp. are elevated in irrita-
ble bowel syndrome pediatric patients (Saulnier et al.,
2011). Members of the same phylogenetic group were
found to correlate with irritable bowel syndrome symp-
tom score in an independent study (Rajilic-Stojanovic
et al., 2011). Haemophilus spp. are relatively frequently
detected in the upper parts of the gastrointestinal tract of
healthy humans of different ages (Justesen et al., 1984;
Ou et al., 2009), but also can be detected inflamed and
stool specimens from children with diarrhea, with rela-
tively low prevalence (Megraud et al., 1988).
Aeromonas spp. are medically significant as these spe-
cies are implicated in the development of the gastroenter-
itis and diarrhea. The role of these bacteria in human
health has been a subject of a long-lasting debate result-
ing in a conclusion that at least four gastrointestinal spe-
cies (A. caviae, A. hydrophila, A. jandaei, and A. veronii),
are pathogenic (Janda & Abbott, 1998). The presence of
these species in the gastrointestinal tract is not necessarily
inducing any symptoms, although in vitro experiments
have indicated that they are cytotoxic and induce lesions
in the intestinal mucosa (Pitarangsi et al., 1982).
The Succinivibrionaceae family groups strictly anaerobic
bacteria that ferment carbohydrates to produce succinate
and acetate. Representatives of three genera of this family
can be detected in the human gastrointestinal tract: An-
aerobiospirillum spp. are motile, spiral bacteria that are
implicated in the development of diarrhea (Malnick,
1997); while Succinatimonas and Succinivibrio representa-
tives are subdominant bacteria that were isolated from
healthy humans (Table S1).
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Members of the Vibrionaceae are pathogens that cause
acute, self-limiting gastroenteritis (Hou et al., 2011). The
natural habitat of Vibrio spp. is the aquatic ecosystem,
and hence they are only rarely detected in the human
gastrointestinal samples — notably after infection that
induces diarrhea.
Eight different Pseudomonas spp. can be detected in the
human gastrointestinal tract. Among them, Pseudomonas
aeruginosa is the most prevalent and was frequently
reported as a member of the fecal microbiota of healthy
humans (Finegold et al., 1974; Benno et al., 1986).
Although a member of the normal gastrointestinal micro-
biota, Pseudomonas aeruginosa can act as an opportunistic
pathogen in critically ill or immuno-suppressed patients
and cause sepsis as it can interact with our immune sys-
tem (Wu et al., 2005) and can disrupt the intestinal epi-
thelial barrier (Zaborina et al., 2006). Pseudomonas
fluorescens is a less prevalent member of the genus that
has been implicated in the development of Crohn’s dis-
ease (Wei et al., 2002). A recent study showed that Pseu-
domonas spp., among other Proteobacteria, have increased
abundance in infants with colic (de Weerth et al., 2013).
Until today, only two bacteria from Xanthomonadaceae
have been isolated from gastrointestinal samples:
Stenotrophomonas maltophilia from a stool and an ileal
sample derived from atypical clinical cases (Tamura et al.,
1988; Apisarnthanarak et al., 2003), and Lysobacter soli in
a recent high-throughput cultivation of the normal gas-
trointestinal microbiota (Lagier et al., 2012a). In addition,
four other related bacterial species were detected based
on the SSU rRNA gene sequence. These bacteria were
previously isolated from different ecosystems and include
Nevskia ramose and Rhodanobacter ginsenosidimutans
from soil, Pseudoxanthomonas mexicana from sludge and
urine, and Silanimonas lenta from a hot spring. Based on
their low prevalence in the gastrointestinal tract, it is
most likely that Xanthomonadaceae are transient members
of the gastrointestinal microbiota.
Deltaproteobacteria
Sulfate-reducing bacteria that cluster within the d class of
the phylum Proteobacteria inhabit the human gastrointes-
tinal tract where they utilize sulfate that can be diet
derived or released from mucins. Human gastrointestinal
tract-associated sulfate-reducing bacteria include the ace-
tate-utilizing Desulfobacter spp., the lactate-, and H2-uti-
lizing Desulfovibrio spp., and the propionate-utilizing
Desulfobulbus spp. (Gibson et al., 1988). This group of
related bacteria has been subject of numerous studies
because the end-product of their metabolism — hydrogen
sulfide — is a highly toxic compound that inhibits buty-
rate oxidation within the colonocytes (Attene-Ramos
et al., 2006). Hydrogen sulfide overproduction in the gas-
trointestinal tract has been linked to ulcerative colitis and
colon cancer. Although some cultivation, studies showed
































































Fig. 23. Phylogenetic tree the human gastrointestinal species that
belong to the family of the Enterobacteriaceae. GenBank Accession
Numbers of the SSU rRNA gene sequence are provided for each
species and the family names are indicated.
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bacteria and ulcerative colitis, the overproduction of
hydrogen sulfide has a stronger correlation with dietary
protein (Magee et al., 2000) than with dietary sulfate
(Deplancke et al., 2003), challenging the hypothesis that
the metabolic activity of sulfate-reducing bacteria is
involved in compromised health, at least in healthy sub-
jects. Sulfate-reducing bacteria are normally present in
low abundance, of approximately 106–107 cells g1 (Fite
et al., 2004), and although at least three different genera
of this group of bacteria can be found in the human gas-
trointestinal tract, only Desulfovibrio spp. are character-
ized below the genus level (Fig. 25). In addition, Bilophila
wadsworthia is another member of Deltaproteobacteria
that is present in approximately half of the studied
humans (Baron et al., 1992; Baron, 1997). Bilophila wads-
worthia is capable of utilizing taurine, which is released
by deconjugation of bile salts or present in the diet, and
also generates hydrogen sulfide as the major end-product.
Its involvement in promoting colitis via taurine metabo-
lism in mice has recently been established (Devkota et al.,
2012).
Epsilonproteobacteria
The class of Epsilonproteobacteria is represented by two





























































Fig. 24. Phylogenetic tree the human gastrointestinal species that belong to the class of the Gammaproteobacteria without Enterobacteriaceae
family. GenBank Accession Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated.
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bacter and Helicobacter. Campylobacter is a genus that
groups diverse isolates from mucosal surfaces of gastroin-
testinal, oral and urogenital tract. The first report of Cam-
pylobacter isolation from the human gastrointestinal tract
dates from 1946 (Levy, 1946). Campylobacter spp. were
originally described as members of genus Vibrio, and
reclassified into an independent genus in 1973 (Veron &
Chatelain, 1973). Species of this genus are principally con-
sidered to be pathogenic organisms involved in diarrheal
illness. However, Campylobacter hominis has been isolated
from a gastrointestinal sample of a healthy subject (Lawson
et al., 2001), while C. concisus is a clinical isolate that also
has been recovered from healthy individual (Engberg et al.,
2000). Finally, a recent study of the microaerophilic fecal
microbiota of children revealed diverse and prevalent colo-
nization of Campylobacter spp. of gastrointestinal tract of
both healthy and children suffering from inflammatory
bowel diseases (Hansen et al., 2013). The presence of Cam-
pylobacter spp. in the gastrointestinal tract can cause watery
or bloody diarrhea, whereas it also can be associated with
intestinal diseases such as ulcerative colitis (Rajilic-Stojano-
vic et al., 2013a). However, Campylobacter spp. can also
remain asymptomatic, suggesting that at least some species
of this genus are commercial members of the gastrointesti-
nal microbiota.
The Arcobacter genus was introduced to accommodate
an independent cluster identified based on the SSU rRNA
gene sequences, of species that were previously classified
within the Campylobacter genus (Vandamme et al., 1991).
These bacteria are also associated with diarrheal disease,
although the prevalence of their isolation, even from clin-
ical samples is very low (Engberg et al., 2000).
The genus Helicobacter has been derived from Cam-
pylobacter after reclassification of the latter (Goodwin
et al., 1989; Vandamme et al., 1991). Helicobacter spp. are
spiral-shaped bacteria that were detected in human gastric
mucosa as late as in 1906 (Krienitz, 1906). They received
exceptional attention once Helicobacter pylori was discov-
ered to induce the gastric and duodenal ulcers (for recent
review see, Fock et al., 2013). Helicobacter spp. are mainly
located in the stomach but can be detected in the other
gastrointestinal samples of healthy individuals but only
when highly sensitive techniques are applied, suggesting
that they may lyse and disappear in transit from the
stomach (MacKay et al., 2003; Ceelen et al., 2005).
Hence, their prevalence is low in samples from the lower
gastrointestinal tract (Hansen et al., 2013).
Lentisphaerae
Victivallis vadensis is the only species within the phylum
of Lentisphaerae that has been isolated from the gastroin-
testinal tract (Fig. 26). This species was isolated in 2003,
































Fig. 25. Phylogenetic tree the human gastrointestinal species that belong to the classes of the Deltaproteobacteria and Epsilonproteobacteria.
GenBank Accession Numbers of the SSU rRNA gene sequence are provided for each species and the family names are indicated. The species
indicated in bold is based on the SSU rRNA gene sequence clustering within the indicated family in contrast to its official classification.
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medium containing cellobiose as the sole carbon source,
but not on the same medium solidified with agar (Zoe-
tendal et al., 2003). Further studies have confirmed its
presence in the gastrointestinal tract of humans (Claesson
et al., 2012), indicating the adaptation of this species
(and most likely the entire bacterial group) to the gastro-
intestinal tract conditions. The genome of this bacterium
has been sequenced (van Passel et al., 2011), revealing a
host of functions, but its activity in the gastrointestinal
tract and its impact on the human host remains to be
determined.
Spirochetes
The first report of the Spirochetes in the human gastrointes-
tinal samples dates from 1923 when a cultivation-based
study reported the 28% prevalence of these bacteria in fecal
samples of healthy individuals (Parr, 1923). The Spirochetes
are established pathogens in veterinary medicine and their
pathogenicity in humans has been debated for a long per-
iod of time. Two species of the phylum Spirochetes can be
detected in the human gastrointestinal samples: Brachyspira
pilosicoli and Brachyspira aalborgi (Fig. 26). Their presence
in the gastrointestinal tract is termed intestinal spirochet-
osis, which in clinical cases is associated with abdominal
pain and diarrhea. However, a retrospective review of cases
diagnosed as intestinal spirochetosis revealed that the pres-
ence of Spirochetes in the gastrointestinal biopsies is often
asymptomatic and may not have pathological significance
(Carr et al., 2010). The question of implication of the Spi-
rochetes in clinical cases might be a question of their density
in the gut. These bacteria typically colonize intestinal
mucosa where they attach and penetrate short distances
into the surface epithelial cells (Harland & Lee, 1967). In
clinical cases of spirochetosis they form a dense biofilm that
covers the entire colonic surface, as indicated by scanning
electron microscopy images (Gad et al., 1977). Another
factor might be relevant to the currently undefined role of
the Spirochetes in human health. A recent molecular study
showed that in addition to the two cultured species,
another, currently uncultured Brachyspira spp. is more fre-
quent than the other two Brachyspira spp. in the human
colonic biopsies. Although this study confirmed the
absence of a correlation between these species and physical
complaints, it appeared that B. pilosicoli is associated with
intestinal inflammation (Westerman et al., 2012).
Another relevant group of the gastrointestinal Spiro-
chetes are formed by the Treponema spp. Members of the
Treponema genus were detected in molecular-based studies
of the gut microbiota of five geographically separate rural
African and Native American tribes (De Filippo et al.,
2010; Tito et al., 2012; Yatsunenko et al., 2012; Ou et al.,
2013; Schnorr et al., 2014). Only in one study, a represen-
tative of this group was identified at species level. A
sequence 99% similar to Treponema berlinense was detected
when analyzing the microbiota coprolite (fossilized feces)
taken from archaeological site in Mexico (Tito et al., 2012).
Treponema spp. are in principle considered to be patho-
genic in industrial societies (Giacani & Lukehart, 2014),
but its reproducible detection in the gastrointestinal micro-
biota of isolated rural communities suggest alternative
symbiotic roles played by these bacteria. These might
include degradation of fiber rich foods and enhancement of
anti-inflammatory capability, as suggested by de Fillipo
and coauthors, who were the first to detected Treponema
spp. in healthy human gut (De Filippo et al., 2010).
Synergistetes
Synergistetes is a recently recognized bacterial phylum that
is typically subdominant in the ecosystems where it resides,




























Fig. 26. Phylogenetic tree the human gastrointestinal species that belong to the different bacterial phyla with limited diversity, and two archaeal
phyla. GenBank Accession Numbers of the SSU rRNA gene sequence are provided for each species and the phylum names are indicated.
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0.01% in human fecal samples (Horz et al., 2006). The first
attempt to detect this group of bacteria in the human gas-
trointestinal tract yielded a sole SSU rRNA gene sequence
that is identical to that of a later on cultured Cloacibacillus
evryensis (Ganesan et al., 2008). Cloacibacillus spp. are
amino acid degrading bacteria that use sulfate as terminal
electron acceptor and that are capable to use mucin as sole
carbon source (Looft et al., 2013). Their presence in the
human gastrointestinal microbiota was confirmed by
several molecular studies. Furthermore, a recent
high-throughput culturomics study retrieved another
gastrointestinal Synergistetes bacterium — Pyramidobacter
piscolens (Lagier et al., 2012a). Pyramidobacter piscolens was
described in 2009, as an asaccharolytic, anaerobic oral
isolate capable of hydrogen sulfide production.
Although a minor group, the gastrointestinal Synerg-
istetes might be relevant for the human health, as indi-
cated by their increased abundance in mucosal samples
associated with colorectal cancer (Chen et al., 2012).
Mucin degradation coupled with hydrogen sulfide pro-
duced by these bacteria might be relevant for the colorec-
tal cancer etiology, since the produced metabolite
increases mucosal apoptosis, goblet cell depletion, and
superficial ulceration (Aslam et al., 1992; Deplancke &
Gaskins, 2003).
TM7 candidate phylum
The TM7 phylum represents a recently recognized, widely
distributed group of yet uncultured filamentous bacteria
(Hugenholtz et al., 2001). These bacteria can be detected
in the human oral cavity and the gastrointestinal tract,
while a recent study of the microbiota along the gastroin-
testinal tract has shown that TM7 bacteria are one of the
common microorganisms, widely distributed among
humans (Stearns et al., 2011). Although the presence of
these bacteria is not determinative of the health status, it
has been shown that different TM7 bacteria inhabit the
gastrointestinal tracts of inflammatory bowel disease
patients and healthy controls (Kuehbacher et al., 2008).
Verrucomicrobia
Currently, only two species within the Verrucomicrbia
phylum have been detected in the human gastrointestinal
tract. Akkermansia muciniphila was described in 2004 as a
unique human gastrointestinal bacterium that is able to
grow on intestinal mucus as a sole carbon source (Derri-
en et al., 2004). This bacterium is widely distributed and
can be detected in fecal material of humans of all age
groups (Collado et al., 2007), and although its abundance
varies between subjects, it is probably one of the members
of the core microbiota. Recent literature shows that
A. muciniphila is important for a healthy host as its
decreased abundance is associated with compromised
health including acute appendicitis (Swidsinski et al.,
2011), ulcerative colitis (Vigsnæs et al., 2012; Rajilic-
Stojanovic et al., 2013a), autism (Wang et al., 2011a),
and atopic diseases (Candela et al., 2012). Finally, the
abundance of A. muciniphila is inversely correlated with
obesity (Karlsson et al., 2012). A recent study suggests
that A. muciniphila plays a pivotal role in obesity as its
duodenal delivery regulates fat-mass gain, metabolic
endotoxemia, adipose tissue inflammation, and insulin
resistance in an animal model experiment (Everard et al.,
2013). Given the very short history of the research related
to A. muciniphila, the wealth of data that support its
beneficial role provides evidence of the remarkable
importance of this bacterium. In addition, one other spe-
cies of the Verrucomicrobia — Prosthecobacter fluviatilis —
has been detected in the study of bacteria of a patient
with ileal pouch (McLaughlin et al., 2010), while
sequences classified within this genus were detected in the
study of the microbiota of infants (Palmer et al., 2007).
Other gastrointestinal bacterial phyla
There are a few gastrointestinal bacterial phyla with low
diversity that have not yet been discussed, including the
Deinococcus-Thermus bacteria, the Melainabacteria the
Gemmatimonadetes and the Planctomycetes (Fig. 26). The
Deinococcus-Thermus bacteria were for the first time asso-
ciated with the human gastrointestinal microbiota in
2006, when uncultured phylotypes within this phylum
were recovered in a molecular survey of the microbiota of
the human stomach (Bik et al., 2006). Several studies
have confirmed the presence of these bacteria in the gas-
trointestinal microbiota, while a recent high-throughput
culturing study detected a single cultivated bacterium of
this phylum (Lagier et al., 2012a). Currently, no particu-
lar function has been assigned to this bacterial group,
although there is evidence that these bacteria are active in
the distal parts of the gastrointestinal tract (Peris-Bondia
et al., 2011).
Molecular studies have retrieved SSU rRNA gene
sequences from the gastrointestinal tract of humans and
other animals that cluster into a distinct clade, related to,
but separate from cultured photosynthetic Cyanobacteria
(Ley et al., 2005). A novel name – Melainabacteria — was
recently proposed for this group of bacteria (Di Rienzi
et al., 2013). Sequences representing these bacteria were
detected in the stomach (Andersson et al., 2008), while
two independent studies have shown that these bacteria
are active in the distal part of the human gastrointestinal
tract (Rajilic-Stojanovic et al., 2008; Peris-Bondia et al.,
2011), which indicates their wide distribution along the
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gastrointestinal tract. The role of these bacteria in the
ecosystem is currently undetermined and although no
cultured representatives are available now, the genomes of
these bacteria have been sequenced and annotated. Based
on the genomic information, it was concluded that these
are motile, strictly anaerobic, fermentative bacteria (Di
Rienzi et al., 2013).
In addition to the bacterial phyla that are reproducibly
detected by many studies of the human gastrointestinal
microbiota, some bacterial phyla are only occasionally
found. For instance, some studies have reported the pres-
ence of the Gemmatimonadetes in the human gastrointes-
tinal tract (Andersson et al., 2008), but even when
present, these bacteria constitute an extremely minor frac-
tion, as indicated by the fact that only one of over 15 000
SSU rRNA gene sequences in the study of the microbiota
of inflammatory bowel disease patients and controls orig-
inated from a Gemmatimonadetes bacterium (Frank et al.,
2007). Furthermore, a few pyrosequencing studies have
reported Nitrospira bacteria in the human gastrointestinal
tract (Hung et al., 2011). It is interesting to note that in
a recent study of the microbiota of pediatric irritable
bowel syndrome patients only one Nitrospira phylotype
was detected by pyrosequencing. However, the further
attempts to retrieve this bacterium revealed that the
detected sequence was actually retrieved from a novel
taxon related to the genus Ruminococcus (Saulnier et al.,
2011). This example testifies to the fact that identification
of sequences based on very short reads, such as those
produced by currently used high-throughput sequencing
technologies, are not always reliable (Werner et al., 2012).
The presence of the Planctomycetes in the human gas-
trointestinal tract was reported only in molecular-based
studies (Wilson & Blitchington, 1996; De Filippo et al.,
2010; Hong et al., 2011). A sequence of an uncultured
bacterium (Gene Bank Accession Number U58225) was
reported in one of the first molecular studies of the
human gastrointestinal microbiota, and was designated as
an uncultured Plantomycetes bacterium (Wilson & Blitch-
ington, 1996). However, the detected SSU rRNA gene
sequence was probably retrieved from a representative of
a new genus within the Lentisphaerae phylum, since it has
the highest similarity (88%) with V. vadensis (that was
isolated and described after publication of the molecular
study). Nevertheless, Plantomycetes might be a part of the
human gastrointestinal microbiota, as a recent review
indicated the detection of a diverse community of the
Planctomycetes in the human gastrointestinal tract (Lagier
et al., 2012b). When analyzing the publicly available data,
we found that only one (JQ287572) had high similarity
(98%) to the SSU rRNA gene sequence of a cultured bac-
terium—Schlesneria paludicola. However, based on the
characteristics of this bacterium (e.g., it grows in the
temperature range 4–32 °C), it is not likely that this bac-
terium resides in the human gastrointestinal tract.
Archaea
Bacteria are the dominant but not an exclusive compo-
nent of the human gastrointestinal microbiota. Archaea,
primarily the methanogenic ones, can be relatively abun-
dant component of the gastrointestinal microbiota with
densities of up to 1010 cells g1 of feces (Bond et al.,
1971; Miller & Wolin, 1986). In total, eight archaeal spe-
cies have been associated with the human gastrointestinal
tract (Fig. 26, Table S2). In an early cultivation study,
which dates from 1968, a single methanogenic species,
isolated from four of five individuals, was identified as
Methanobrevibacter ruminantium (Nottingham & Hun-
gate, 1968). Today, Methanobrevibacter smithii is recog-
nized as the most abundant, and often an exclusive
methanogen of human gastrointestinal microbiota (Miller
& Wolin, 1986; Dridi et al., 2009), which suggests a pos-
sible misidentification of the isolates in the earlier study.
In addition to M. smithii, Methanosphaera stadtmaniae is
a relatively prevalent, but atypical methanogenic archaea
that reduces methanol and that can be found in human
feces in low concentrations (Miller & Wolin, 1985; Dridi
et al., 2009). Similar to M. stadtmaniae, a recently iso-
lated Methanomassiliicoccus luminyensis can also utilize
methanol in the presence of hydrogen, but these two gas-
trointestinal archaeal species are phylogenetically distant
(Dridi et al., 2012). Methanogenic archaea have been
extensively studied as the process of methane synthesis
from carbon dioxide and hydrogen results in a significant
gas removal in the gastrointestinal tract. The role of
methanogenic archaea might be particularly relevant for
bloating, which is one of the symptoms of irritable bowel
syndrome, and a recent study has shown a highly signifi-
cant (fourfold) reduction of methanogenic archaea in irri-
table bowel syndrome patients relative to controls
(Rajilic-Stojanovic et al., 2011). In addition to methano-
genic archaea, two cultured species of halophilic archaea
have been detected in the study of the microbiota of Kor-
ean subjects (Nam et al., 2008), while the presence of low
numbers of these organisms was confirmed by the analy-
sis of the colonic mucosa of inflammatory bowel patients
(Oxley et al., 2010). In addition to the confirmed pres-
ence of the Euryarchaeota phylum members, the human
gastrointestinal archaea might also include a number of
yet uncultured species within the Thermoplasma and the
Crenarchaeota phylum and putative novel orders, as
detected in molecular-based studies and recently reviewed
(Dridi et al., 2011). The presence of Crenarchaeota phy-
lum representatives was detected by retrieving the specific
partial SSU rRNA gene sequences in a study that dates
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from 2005 (Rieu-Lesme et al., 2005). One of the ampli-
fied SSU rRNA gene sequences (AY887079) shows 97%
sequence similarity with SSU rRNA gene sequence of
Sulfolobus solfataricus, and another (AY887074) 99%
sequence similarity with the SSU rRNA gene of Candida-
tus Nitrososphaera gargensis. It should be noted that both
Sulfolobus solfataricus and Nitrososphaera gargensis are hy-
perthermophilic species, and it is highly unlikely that
these species inhabit the gastrointestinal tract of humans.
Until cultured representatives or at least the full SSU
rRNA gene sequences of the Crenarchaeota species are
obtained in the future independent studies, the presence
of the this archaeal phylum in the human gastrointestinal
tract remains questionable.
Eukarya
Different microeukaryal species can be detected in the
human gastrointestinal tract, and although this group of
organisms is subdominant, it is widely distributed com-
ponent of the gastrointestinal microbiota. The first molec-
ular-based study of this component of the gastrointestinal
microbiota was published only recently (Scanlan & Mar-
chesi, 2008). Very few other studies have been reported
since, and the results of these have been recently summa-
rized (Hamad et al., 2013). The most prevalent human
gastrointestinal Eukarya are yeasts, while a number of dif-
ferent microeukaryal intestinal parasites can be detected
in the human gastrointestinal samples. These species have
been excessively studied by epidemiologists, and although
their presence is in most cases the result of an infection
with contaminated food or water, some species establish
in healthy humans and are probably a part of the normal
gastrointestinal microbiota of some humans (Scanlan &
Marchesi, 2008).
Fungi
The most prevalent Eukarya in the human gastrointestinal
tract are yeast-like fungi and in total 57 intestinal species
distributed between the two phyla, Ascomycota and Basidi-
omycota, have been detected (Fig. 27). The first report of
yeasts in the human gastrointestinal tract dates from 1901
when Candida albicans was isolated from feces of patients
infected with tropical sprue (Kohlbrugge, 1901). A thor-
ough analysis of the yeasts diversity in the gastrointestinal
tract in the early twentieth century showed that yeasts can
be detected in about one out of five subjects and that the
detected yeast community is similar in healthy subjects and
patients suffering from various gastrointestinal disorders
(Anderson, 1917). A recent molecular analysis of the fungal
diversity allowed for detecting low amounts of fungi in any
studied subject (Ott et al., 2008). Among yeasts, Candida
spp. are the most prevalent and there is considerable evi-
dence that C. albicans and C. rugosa are part of the normal
gastrointestinal microbiota, while other Candida spp. are
scarcely detected in gastrointestinal samples (Fig. 27,
Table S3). Candida albicans is early established in the eco-
system, as illustrated by the fact that it can be detected in
over 95% of 1-month-old infants (Kumamoto & Vinces,
2005). Candida spp. are subdominant in the ecosystem and
typically present in densities lower than 106 cells g1 of
intestinal content (Anderson, 1917; Finegold et al., 1974;
Finegold et al., 1977). Although the natural environment
of Candida spp. is the gastrointestinal tract, where they are
either symbiotic or commensal to the human host, under
specific circumstances these organisms can cause a variety
of candidiasis in different organs of the human body. It has
been proposed that in the developed world the increased
intake of drugs, processed foods and pollutants can cause
overgrowth of Candida spp. and trigger a Candida-associ-
ated complex of symptoms (Schulze & Sonnenborn, 2009).
This might be relevant for gastrointestinal health, as it has
been shown that Crohn’s disease patients and their first rel-
atives have a significantly higher abundance of Candida
spp. compared to the controls (Standaert-Vitse et al.,
2009). Furthermore, there is a considerable overlap
between the symptoms of the irritable bowel syndrome,
and the symptoms of intestinal candidiasis (Santelmann &
Howard, 2005), although the association between the irri-
table bowel syndrome and Candida spp. has not been ade-
quately studied. Other yeasts in the gastrointestinal tract
include several Saccharomyces spp., of which Saccharomyces
cerevisiae was the most reproducibly detected in molecular
studies (Nam et al., 2008; Ott et al., 2008; Scanlan & Mar-
chesi, 2008). Furthermore, Galactomyces geotrichum has
been detected in the human fecal samples using molecular
techniques (Scanlan & Marchesi, 2008) and cultivation
(Gouba et al., 2013; Hamad et al., 2013). In contrast to
Candida spp. that have the gastrointestinal tract as their
natural niche, both Saccharomyces spp. and G. geotrichum
are yeasts that are used in food production and their detec-
tion in fecal samples of humans could be a result of the
dietary intake prior to sampling. This hypothesis is sup-
ported by the results of the recently published gastrointesti-
nal microbiota analysis of adults on extreme diets, as a
number of foodborn microorganisms (including yeasts)
were detected in the gastrointestinal tract of subjects on
animal-based (meat and cheese rich) diet (David et al.,
2014).
Filamentous fungi are another group of Eukarya that
can be present in the human gastrointestinal tract.
Although they are not widely distributed, their presence
was noticed in a number of studies (Finegold et al., 1974;
Finegold et al., 1977; Benno et al., 1986). Several
Aspergillus spp. and Penicillium spp. have been identified
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during a 9-year long culture-based monitoring of an
immunodeficient child’s microbiota (Taylor et al., 1985),
while different species of these two genera have been
detected in recent years using both cultivation on various
media (Gouba et al., 2013), or molecular-based methods
(Scanlan & Marchesi, 2008). Many of these species are
associated with dietary sources, as they are used as start-
ers for cheese production or ripening, whereas some are
just food contaminants. Having in mind their source, and
instability (as illustrated in the results of longitudinal fol-
low up of fungal microbiota; Scanlan & Marchesi, 2008),
it is likely that these fungi are not a constant and func-
tionally relevant part of the gastrointestinal microbiota.
Eukarya-intestinal parasites
The gastrointestinal tract of humans can be inhabited by
a number of different micro-eukaryotes that belong
to the phyla: Apicomplexa, Amoebozoa, Ciliophora,
Metamonada, Micosporidia, Parabasalia, and Stramenopiles
(Fig. 28). Some of these organisms are pathogenic infec-
tious agents, which after ingestion (through contaminated
water or food) can cause gastrointestinal symptoms, most
frequently diarrhea. Because of their clinical significance,
these organisms, which are often referred as intestinal
protozoa, are relatively thoroughly studied as infections
agents. Little attention has been given to these organisms
in terms of their role in the ecosystem, but as several
studies have shown that some of these species can be pres-
ent in the healthy human gastrointestinal tract, it is
reasonable to expect that future research will reveal the
true role of these organisms in the gastrointestinal
microbiota.
A number of Eukarya classified within the phylum of
Apicomplexa in addition to Micosporidia form a group of





























































Fig. 27. Phylogenetic tree the human
gastrointestinal Fungi. GenBank Accession
Numbers of the SSU rRNA gene sequence are
provided for each species and the phylum
names are indicated.
FEMS Microbiol Rev 38 (2014) 996–1047ª 2014 The Authors. FEMS Microbiology Reviews
published by John Wiley & Sons Ltd on behalf of Federation of European Microbiological Societies.
1032 M. Rajilic-Stojanovic & W.M. de Vos
infections, primarily in the epithelial cells of the
gastrointestinal tract. All Apicomplexa species that can be
retrieved from the human gastrointestinal tract are con-
sidered to be pathogenic (Farthing, 2006). Cryptosporidi-
um parvum is the most widely distributed representative
of the group, and it has a high prevalence of infection in
children of the developing world (Checkley et al., 1997).
Although infections with Cryptosporidium parvum can be
asymptomatic, even when it does not cause diarrhea, this
organism affects absorption of nutrients and has a nega-
tive effect on weight gain of children (Checkley et al.,
1997).
Blastocystis spp. (classified within the Stramenopiles) are
single-celled protozoan organisms. Blastocystis spp. was
for the first time isolated from the human gastrointestinal
tract in 1911 and was reported under name Blastocystis
enterocola, which was, at the time, designated as yeast
(Alexieff, 1911). According to the current convention, all
Blastocystis isolated from humans are identified as Blasto-
cystis hominis, although their SSU rRNA gene sequence
analysis showed that nine different phylotypes of these
organisms can be detected in the human gastrointestinal
tract (Arisue et al., 2003; Scanlan & Marchesi, 2008). This
‘within species’ diversity of the B. hominis can explain the
fact that the role of Blastocystis in human disease is still
not defined (Zierdt, 1991). Longitudinal study of the
Eukarya in the human gastrointestinal tract has shown
that Blastocystis spp. are stable and frequently detected
organisms in healthy subjects (Scanlan & Marchesi,
2008). Although some authors have suggested the link
between Blastocystis and intestinal diseases such as
diarrhea, irritable bowel syndrome and inflammatory
bowel disease, the detection of Blastocystis in 105 patients
suffering from various gastrointestinal diseases and 96
healthy controls, indicated that Blastocystis is equally fre-
quent in patients and healthy subjects, although different
phylotypes of Blastocystis are associated with different
health status (Dogruman-Al et al., 2008). Another recent
study could establish a significantly higher incidence of
Blastocystis in ulcerative colitis patients, when compared
to controls (Cekin et al., 2012).
Neobalantidium coli is the only representative of the
Ciliophora phylum. Neobalantidium coli is the largest pro-
tozoan parasite that infects humans, but its natural hosts
are pigs. Although the organism can reproduce within the
intestinal lumen of humans without attacking the tissues
and therefore remain asymptomatic, the infection with
this species is typically followed by diarrhea and bloody
stools (Katz et al., 1982).
The Amoebozoa that can be detected in the human gas-
trointestinal tract include Endolimax nana and Iodamoeba
b€utschlii and six Entamoeba spp. (Table S3). The SSU rRNA
gene sequence is available only for five Entamoeba spp.
(Fig. 28). While most of the intestinal Amoebozoa are non-
pathogenic, there is sufficient evidence that Entamoeba his-
tolytica is pathogenic for humans and causes amebiasis —
dysentery or amebic colitis with a high mortality rate (Fote-
dar et al., 2007). Entamoeba histolytica was the first
described 1875, although the species name Entamoeba
histolytica was assigned later, in 1903 by Fritz Schaudinn
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Fig. 28. Phylogenetic tree the human gastrointestinal microeukarya. GenBank Accession Numbers of the SSU rRNA gene sequence are provided
for each species and the phylum names are indicated.
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(Saklatvala, 1993). There are several studies that show the
successful detection of Entamoeba spp. in clinical samples
using molecular methods, typically in stool samples taken
from patients with diarrhea. Molecular studies of the Euk-
arya as part of the ecosystem in the human gastrointestinal
tract already confirmed the presence of two Entamoeba spe-
cies: Entamoeba coli (Scanlan & Marchesi, 2008) and Ent-
amoeba hartmanni (Hamad et al., 2013) in the
gastrointestinal tract of a healthy man.
Members of the phyla Micosporidia, Parabasalia and
Metamonada are micro-eukaryotic organisms that contain
flagella and are often commonly termed as flagellates.
Micosporidia are obligate intracellular protozoan parasites
that spread in the environment via spores. Four species
of Micosporidia can infect the human gastrointestinal tract
— Enterocytozoon bieneusi (Desportes et al., 1985), En-
cephalitozoon intestinalis (Weber et al., 1994), Encephalito-
zoon cuniculi (Franzen et al., 1995), and Retortamonas
intestinalis (Jones-Engel et al., 2004; Fig. 28, Table S3).
Retortamonas intestinalis, for which SSU rRNA gene
sequence is not available, is the oldest isolate of this
group that was for the first time cultured in 1879
(Hogue, 1933). Other Micosporidia were isolated from the
gastrointestinal tract of a subject infected with HIV (Des-
portes et al., 1985). The presence of Micosporidia in the
gastrointestinal tract is typically associated with diarrhea,
mostly in immuno-suppressed patients, although spores
of these organisms can be detected in gastrointestinal
samples of asymptomatic subjects (Cegielski et al., 1999;
Mungthin et al., 2005; Wichro et al., 2005). If asymptom-
atic, the presence of Micosporidia in the gastrointestinal
tract is associated with malnutrition.
Among Parabasalia, two species can be associated
with the human gastrointestinal tract. Pentatrichomonas
hominis is generally regarded as a harmless commensal
organism, although it is occasionally designated as a
causal agent of diarrhea. This organism, which actually
represents the oldest gastrointestinal isolate retrieved in
1854, has a low prevalence of the human gastrointestinal
tract colonization that varies from 0.1% to 30.9%
depending on the geographical location (Honigberg,
1990). In 1918 another member of this group, Dient-
amoeba fragilis was reported as a commensal in the
human gastrointestinal tract. However, the latter
research has suggested that D. fragilis might be associ-
ated with a number of diseases including diarrhea,
abdominal pain, anorexia, irritable bowel syndrome or
allergic colitis (reviewed in Johnson et al., 2004). The
uncertainty of the pathogenicity of D. fragilis might be,
similar to B. hominis, due to the presence of different
phylotypes, since two different phylotypes of this species,
with 2% SSU rRNA gene sequence divergence, have
been identified (Johnson & Clark, 2000).
The Metamonada phylum includes Giardia lamblia
and two rarely detected and principally nonpathogenic
species — Enteromonas homins and R. intestinalis (Katz
et al., 1982). Giardia lamblia is the most common flagel-
late of the human gastrointestinal tract. When ingested,
typically via contaminated food or water, G. lamblia
attaches to the mucosal surface of the duodenum or
jejunum and multiplies by binary fission (Wolfe, 1992).
Infection with G. lamblia is termed giardiasis, and
although it may remain asymptomatic, giardiasis can be
followed by a range of symptoms that include steator-
rhoea, diarrhea and weight loss (Wolfe, 1992). It is not
clear why some infections are asymptomatic, but already
in the 1970s, it was suggested that the symptoms might
depend on the relation between the parasite and the
enteric gastrointestinal microbiota (Tandon et al., 1977).
Postinfective to the giardiasis, patients might develop a
range of novel symptoms that resemble those of the irri-
table bowel syndrome (Hanevik et al., 2009). This con-
dition, which can be developed after infection with
other infectious agents, such as Campylobacter spp., is
recognized as postinfectious irritable bowel syndrome
(Spiller & Garsed, 2009). A recent study showed that
the bacterial fraction of the gastrointestinal microbiota
of the postinfectious irritable bowel syndrome patients
have a distinct composition relative to controls, which
most likely reflects a consequence of an intensive inter-
action between the ecosystem and the infectious agent
(Jalanka-Tuovinen et al., 2013). This illustrates that
infectious agent, although not true members of the gas-
trointestinal microbiota should be kept in mind when
studying the gastrointestinal microbiota, as their short-
and long-term impact on the microbiota composition
and function can be profound.
Concluding remarks
The knowledge generated during more than a century of
studying the human gastrointestinal microbiota has
shown that this ecosystem is indeed a forgotten organ of
the human body. The wealth of data about the gastroin-
testinal microbiota is highly scattered in time as well as
in space — a caveat that this review aims to correct in an
attempt to systematize the generated knowledge. We have
given particular attention to the diversity and the defined
functions of the abundant and important microbiota
groups. Our inventory reports 1057 cultured gastrointesti-
nal species, while many more are still expected to be cul-
tured. Although cultivation of the gastrointestinal
microbiota is laborious, it is an essential step for the
detailed physiological and biochemical characterization of
the individual gastrointestinal isolates that is needed for
the progress of this research field. This has been
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increasingly recognized and the recent high-throughput
culturing studies have proven that cultivation can be used
as a powerful methodology in discovery of currently
unknown gastrointestinal inhabitants (Lagier et al., 2012a;
Dubourg et al., 2013; Pfleiderer et al., 2013). The future
cultivation of the remaining majority of the gastrointesti-
nal microbiota is expected to improve our understanding
of this ecosystem, while this review can serve as a baseline
for the gastrointestinal microbiota diversity and function
when the first 1000 intestinal species had been discovered.
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